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ABSTRACT 
Phytosterols are a group of plant sterols and are popular cholesterol-lowering 
functional food. Similar to cholesterol, phytosterol such as P-sitosterol is susceptible 
to oxidation during food processing. Previous reports showed that phytosterols are 
protective to cardiovascular systems by reducing circulating LDL cholesterol levels 
while cholesterol oxidation products impair endothelium-dependent relaxations in 
vasculature. The objectives of this study were to investigate the effect of several 
phytosterols and P-sitosterol oxidation products (SOPs) on endothelium-dependent 
relaxations of endothelium-impaired and healthy rat aorta and to investigate their 
effects on the vascular smooth muscle of rat aorta. 
SOPs attenuated endothelium-dependent, acetylcholine (ACh)-induced 
relaxations; this attenuation was totally restored by indomethacin [a non-selective 
cyclooxygenase (COX) inhibitor], DuP-697 (a selective COX-2 inhibitor) and SI8886 
(thromboxane-prostanoid receptor antagonist). Western blotting analysis showed that 
SOPs increased COX-2 expression. Levels of reactive oxygen species (ROS) were 
elevated in rat aortic endothelial cells exposed to SOPs. Furthermore, SOPs-induced 
attenuation in endothelium-dependent relaxations was reversed by ROS scavenger 
tempol and tiron, NADPH oxidase inhibitor DPI, and xanthine oxidase inhibitor 
oxypurinal. In particular, both elevation of ROS levels and up-regulation of COX-2 
v i i i 
were normalized by tempol. To conclude this part, SOPs impaired 
endothelium-dependent relaxations via a ROS-dependent up-regulation of COX-2 
expression. 
In addition, SOPs induced relaxations in high-K+-preconstricted 
endothelium-denuded aorta. This effect was abolished by the calcium opener Bay K 
8644, potentiated by the NCX inhibitor nickel while not affected by thapsigargin 
(SERCA inhibitor) and ouabain (Na+/K+-ATPase inhibitor). Furthermore, SOPs 
inhibited concentration-dependent contractions to Phenylephrine, U46619 and K.. In 
summary, apart from its detrimental role in endothelium function, SOPs exerted 
potential blocking effect on VOCC in VSMCs. 
On the other hand, in endothelium-intact aorta, ACh-induced relaxations were 
attenuated by a ROS-generating chemical homocysteine (HC). The impaired 
relaxations were reversed by treatment with brassicasterol, P-sitosterol, and 
stigmasterol. DPPH assay showed that all of the three phytosterols did not exert direct 
free radical-scavenging activity. Western blotting experiments demonstrated that nitric 
oxide synthase (eNOS), COX and SOD expression were not altered in rat aorta upon 
exposure to HC or brassicasterol plus HC. In addition, the HC treatment elevated 
intracellular ROS in a time-dependent pattern in primary aortic endothelial cells. 
However, brassicasterol failed to reverse the intracellular ROS levels which were 
i x 
elevated upon HC treatment. In contrast, brassicasterol alone induced a significant 
increase in the intracellular ROS levels, which did not present a functional effect. 
Finally, HC inhibited the NO production upon 10 juM ACh in primary aortic 
endothelial cells as determined by the DAF-FM fluorescence. Brassicasterol had a 
trend to abolish the effect of HC by restoring the NO production. In conclusion, 
brassicasterol restored the HC-attenuated endothelium-dependent relaxations by 
enhancing the NO bioactivity. 
The present study provides novel experimental evidences showing the beneficial 
effects ofphytosterols on the endothelium function and paradoxical effect of SOPs on 
the vasculature, that is, harmful effects of SOPs on the endothelium function while 
potential blocking effect of VOCC in VSMCs. In summary, the safety profile of 
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Chapter One Introduction 
1.1 Occurrence and structure of phytosterols in plants 
Phytosterols are plant-derived sterols that are functionally analogous to 
cholesterol in vertebrate animals. Phytosterols have similar structure with cholesterol 
but differ from that of cholesterol in the presence of modified side chains at C-24 
(Ling and Jones 1995). The commonly occurred phytosterols in nature include 
P-sitosterol, campesterol, stigmasterol and brassicasterol. Their chemical structure is 
shown as Figure 1.1 (Ostlund 2002). Beneke firstly reported the discovery of 
phytosterol obtained from olive oil in 1862 (Gill and Tufts 1903; Chan, Demonty et al. 
2007). Interestingly, the author mistook the phytosterol with cholesterol due to the 
poor analytical technique at that time. It was not until more than 50 years later when it 
was established that the compound Beneke reported was actually sitosterol. 
Nowadays, more than 200 different sterols and related compounds from phytosterols 
have been identified from various plant materials (Sanclemente, Marques-Lopes et al. 
2009). 
Phytosterols naturally exist in edible plants as well as herbs, shrubs, and trees. 
Pollak et al. described the presence and distribution of phytosterols across plant 
species (Pollak and Kritchevsky 1981). Phytosterols are usually detectable at various 
levels in the fat-soluble fraction of seed, root, stem, branch, leaf, and blossom. The 
phytosterol content of any given plant also depends on length of daylight, degree of 
soil alkalinity, and time of plant harvest. In general, these compounds are particularly 
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abundant in cereals, nuts, seeds, and oils derived from them (Moreau, Whitaker et al. 
2002). What's more, phytosterols are the largest nontriacylglycerol component of 
refined vegetable fats (Ito, Tamura et al. 1973). In all plant tissues, phytosterols occur 
in five common forms: as the free alcohol, as fatty-acid esters, as steryl glycosides, as 
acylated steryl glycosides and as hydroxycinnamate steryl ester (Moreau, Whitaker et 
al. 2002). 
Cholesterol / 
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Figure 1.1 Cholesterol and common phytosterols 
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1.2 Biological effects of phytosterols 
Phytosterols are most famous for their significant effect in decreasing the 
circulating cholesterol levels, which are believed to be one of the major causes of the 
initiation and progression of the atherosclerotic process (Pentikainen, Oomi et al. 
2000; Wang, Greilberger et al. 2001). Previous studies showed that food 
supplemented with phytosterols has significant cholesterol-lowering effects. In 
addition, phytosterols also possess anti-cancer effects, anti-proliferative effects, 
anti-inflammatory and immune function-modulating effects (Alappat, Valerio et al.). 
Taken together, phytosterols possess various beneficial biological activities apart from 
the well-known cholesterol-lowering effect. 
1.2.1 Cholesterol-lowering effect of phytosterols 
In recent years, phytosterols have attracted much attention due to their 
significant effect in decreasing the circulating cholesterol levels, which are believed to 
be one of the major causes of atherosclerotic process. Previous studies showed that 
food supplemented with phytosterols has significant cholesterol-lowering effect. Low 
doses of soy protein added with P-sitosterol significantly decreased LDL-cholesterol, 
triglyceride and apoB levels and increased HDL-cholesterol and apoA plasma 
concentrations in moderately hypercholesterolemic subjects (Cicero, Fiorito et al. 
2002). A significant cholesterol lowering effect of low dosages of plant sterols was 
also observed in healthy normocholesterolaemic individuals (Hendriks, Weststrate et 
3 
al. 1999). The plasma total- and LDL-cholesterol concentrations can be significantly 
reduced by 8-13% when margarines enriched in soybean oil sterol-esters or 
sitostanol-ester are consumed. 
Previous study showed that phytosteols that were naturally present in 
commercial com oil significantly reduced cholesterol absorption in humans (Ostlund 
2002). 
It is generally accepted that phytosterols inhibit intestinal absorption of 
cholesterol. Figure 1.2 illustrates the possible mechanisms of how phytosterols work 
in physiological environment (Ling and Jones 1995). 
Diet 
I I ^ + blood 
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Figure 1.2 The possible mechanisms of how phytosterols decrease cholesterol level in 
physiological environment. On one hand, phytosterols could directly inhibit 
cholesterol absorption through displacement of cholesterol from micelles in small 
intestine. On the other hand, the circulating phytosterols can promote the synthesis of 
cholesterol from Acetyl-CoA in liver, which would enhance the excretion of 
4 
cholesterol from human body so as to decrease the circulating cholesterol levels. 
1.2.2 Anti-cancer effect of phytosterols 
Mounting evidences suggested that phytosterols possessed anti-cancer effects. 
Increased intake of dietary phytosterols are reported to be correlated to a lower risk of 
colon cancer by both epidemiological and experimental studies(Rao and Janezic 
1992). A control-case study revealed that plant sterol intake showed significant 
protective effect in lung adenocarcinoma(Mendilaharsu, De Stefani et al. 1998). 
Campesterol was reported to possess potential antiangiogenic effect via an inhibition 
of endothelial cell proliferation and capillary differentiation (Choi, Lee et al. 2007). In 
addition, phytosterols significantly inhibited the growth of human prostate cancer 
PC-3 cells. Furthermore, there are evidences suggesting that phytosterols possess 
anti-cancer effects against stomach (De Stefani, Boffetta et al. 2000) and ovary 
cancer(McCann, Freudenheim et al. 2003). It is proposed that phytosterols can 
alleviate cancer development by reducing the production of oxidative stress, which is 
believed to be one of the carcinogens (Woyengo, Ramprasath et al. 2009). Evidence 
showed that P-sitosterol increased the activities of antioxidant enzymes, superoxide 
dismutase and glutathione peroxidase in cultured macrophage cells with oxidative 
stress, indicating that phytosterols can protect cells from damage by ROS (Vivancos 
and Moreno 2005). 
1.2.3 Anti- proliferative effect of phytosterols 
The anti-proliferation effect of phytosterols on the vascular smooth muscle cell 
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(VSMC) growth and function is considered to be an indication of protection against 
atherosclerosis since VSMC plays a central role in the development of atherosclerosis. 
Therefore, many studies examined the effect of dietary phytosterol on the growth and 
function of VSMC. It was reported that P-sitosterol concentration-dependently 
inhibited proliferation of rat aortic smooth muscle cells without cytotoxic effect 
(Chien, Lee et al. ； Mahajan and Mehta). Another study compared the inhibition effect 
of P-sitosterol, campesterol and cholesterol supplementation on the growth and 
proliferation of VSMC. P-Sitosterol was found to inhibit VSMC growth more 
effectively than campesterol while cholesterol showed no effect on cell growth and 
proliferation(Awad, Smith et al. 2001). The results suggested that dietary phytosterols 
may offer protection by inhibting the hyperproliferation of VSMC found in 
atherosclerosis. Except for VSMC, dietary phytosterols were also reported to 
significantly abolish the rat proximal colon cell proliferation that was increased by 
cholic acid (Awad, Hernandez et al. 1997). 
1.3 Intake and absorption of phytosterols in human beings 
Diets are the only source of phytosterols in human beings since phytosterols 
cannot be endogenously synthesized in our bodies (Schoenheimer 1931; Ling and 
Jones 1995). Absorption of P-sitosterol was 5% (or less) of daily intake, which is 
considerably lower than that of cholesterol ranging from 45% to 54% of intake (Salen, 
Ahrens et al. 1970; Salen, Shore et al. 1989). No endogenous synthesis of P-sitosterol 
was observed in the patients studied (Salen, Ahrens et al. 1970). 
6 
Dietary phytosterol intakes among different countries are quite different based 
on the type and amount of plant foods that are consumed in the daily diet. In Japan, 
phytosterol intakes had remained around 373 mg/day while cholesterol consumption 
simultaneously increased over two-fold from 1957 to 1982(Hirai, Shimazu et al. 
1986). The Tarahumara Indians of Mexico, whose diet contained unusually high 
amounts of beans and com, reportedly intook over 400 mg/day of phytosterols while 
very low intake of cholesterol with the amount of less than 100 mg/day (Cerqueira, 
Fry et al. 1979). Western diets typically contain remarkable lower levels of 
phytosterols than diets of many other parts of the world. According to National Food 
Survey in British, daily intakes of several phytosterols were estimated, the main ones 
being P-sitosterol, campesterol, stigmasterol and 57-stigmastenol whose intakes were 
104, 49, 10 and 4 mg/day, respectively, in 1991 (Morton G.M. 1995). Several studies 
have shown populations consuming a predominantly plant-based diet have a lower 
incidence of cardiovascular disease (CVD) when compared with meat-based diets. 
Vegetarian and Asian diets not only contain lower levels of fat and cholesterol but also 
a large variety of phytochemicals, which may function in our bodies (Awad, Smith et 
al. 2001). 
It's furthermore indicated that P-sitosterol is absorbed from the intestine only 
about on tenth as effectively as cholesterol and that it is secreted into the bile more 
rapidly than cholesterol. In addition, it appears to be esterified more slowly than 
cholesterol and it is also distributed differently between the two theoretical body pools. 
These evidences may address why P-sitosterol has considerably lower absorption rate 
7 
than cholesterol (Salen, Ahrens et al. 1970). 
1.4 Occurrence and physiological levels of phytosterol oxidation products (POPs) 
1.4.1 Occurrence of POPs 
The presence of air, light, peroxides in solvents, or heat treatment during the 
cleanup procedure can promote the formation of cholesterol oxidation products 
(COPs) from cholesterol (Rose-Sallin C 1995). Due to the structural similarity, 
phytosterol is likely to be as susceptible as cholesterol to oxidation. There was 
evidence showing that the oxidation behavior of P-sitosterol was similar to that of 
cholesterol in terms of oxidative rate and oxidation products (Xu, Guan et al. 2009). 
Previous studies showed that phytosterol oxides were formed when plant oils 
were subjected to heat treatment or under long-term storage (Dutta and Appelqvist 
1997; Hovenkamp, Demonty et al. 2008). Phytosterols can undergo oxidation in 
food-processing conditions, generating 7-hydroxysterols, 7-ketosterols, 5, 
6-epoxysterols, triols, and 25-hydroxysterols as the major oxidation products (Lampi, 
Juntunen et al. 2002; Bortolomeazzi, Cordaro et al. 2003; Apprich and Ulberth 2004; 
Hovenkamp, Demonty et al. 2008). 
1.4.2 Physiological levels of POPs 
With a daily intake of 2-4 g phytosterols, it is estimated that 2-4 mg phytosterol 
oxides could be ingested (van de Bovenkamp, Kosmeijer-Schuil et al. 1988; Lake and 
Scholes 1997). In fact, this quantity of phytosterol oxides ingested is similar to the 
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quantities of COPs (3-4 mg) presented in the daily diets of people as documented in a 
study in the Netherlands and New Zealand(Tomoyori, Kawata et al. 2004). POPs were 
observed to be absorbed in the intestinal lymphatics in rats. Lymphatic recoveries of 
oxycampesterols and oxysitosterols were even significantly higher than that of 
campesterol and p-sitosterol although lower than that of cholesterol. It was interesting 
to find that the oxyphytosterol diet increased oxycholesterol in the serum compared 
with the phytosterol diet. The observations indicated that exogenous oxyphytosterols 
were well-absorbed and accumulated in the body (Tomoyori, Kawata et al. 2004). 
Diet-derived oxyphytosterols could accumulate in the serum, liver and aorta 
(Tomoyori, Kawata et al. 2004; Ryan, Chopra et al. 2005). Phytosterol oxides are 
present in the plasma from both healthy human subjects (Plat, Brzezinka et al. 2001; 
Grandgirard, Martine et al. 2004) and phytosterolaemic patients(Plat, Brzezinka et al. 
2001). It is reported that cholesterol feeding increases plasma and aortic tissue 
cholesterol oxide levels in parallel (Hodis, Crawford et al. 1991), indicating the 
dietary intake of cholesterol could be a risk factor in enhancing the oxidative stress in 
vasculature. It would be interesting to investigate whether there is possibility that the 
dietary intake of phytosterols could be a risk factor in enhancing the oxidative stress 
in vasculature. 
Recent investigations have demonstrated that POPs are present in the plasma 
of healthy human subjects (Grandgirard, Martine et al. 2004). The physiological 
levels of phytosterols, POPs (Grandgirard, Martine et al. 2004), and especially 
cholesterol and COPs (Dzeletovic, Breuer et al. 1995), have been extensively studied 
9 
due to their impact on health. Table 1.1 summarizes the concentration of total 
cholesterol, P-sitosterol, COPs and SOPs in human plasma/ serum. 
Table 1.1 Concentration of total cholesterol, P-sitosterol, COPs and SOPs in human 
plasma/serum (mean) 
substances plasma/serum 
total cholesterol 1.848 mg/mL 
P-sitosterol 3.35 |ag/mL 
154 ng/mL (27-hydroxycholesterol) 
64 ng/mL (24- hydroxycholesterol) 
GOPs(Dzeletovic，Breuer et al. 1995) 
43 ng/mL (7a- hydroxycholesterol)) 
<30 ng/mL (other oxysterols) 
SOPs(Grandgirard，Marine et al. 2004) 5 ng/mL (7-ketOSitOSterol) 
1 0 
1.5 Endothelium and the vascular tone 
1.5.1 Role of endothelium in the control of vascular tone 
The vascular endothelium is an active and dynamic monolayer of cells that 
serves as a semi-permeable barrier between blood and tissue. Endothelial cells are 
capable of producing and releasing several vasoactive dilating or constricting 
molecules in response to either shear stress or circulating substances which interact 
with respective membrane-bound receptors (Chen, Peng et al. 2009). 
Endothelium-dependent vasodilators such as acetylcholine (ACh), substance P (SP), 
or histamine can stimulate a rise in the intracellular calcium ion concentration ([Ca2+]i) 
of endothelial cells, which in turn activates eNOS or COX. eNOS catalyzes chemical 
conversion of L-arginine to a gaseous signaling molecule, nitric oxide (NO). NO 
readily diffuses toward adjacent vascular smooth muscle cells (VSMC) where it 
activates guanylate cyclase (GC) and induces relaxation. On the other hand, COX is 
responsible for the biosynthesis of prostaglandins or thromboxanes from its precursor, 
arachidonic acid (AA). After liberation from endothelial cells, prostaglandins or 
thromboxanes binds to receptors and might lead to increase in in vascular 
smooth muscle cells (VSMC) which usually induces vascular contraction. Figure 1.3 
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Figure 1.3 Role of endothelial nitric oxide synthase (eNOS) and cyclooxygenase 
(COX) in regulation of the contractility of the underlying vascular smooth muscle. 
1.5.2 Endothelial dysfunction, cholesterol oxidation products (COPs) and 
phytosterol oxidation products (POPs) 
Endothelial dysfunction and activation of the endothelium are predisposed as 
traditional risk factors for atherosclerosis (Ross 1999). Endothelial dysfunction 
usually occurs in early stage of atherosclerosis (Schwartz, Economides et al.； 
Henderson 1991). Endothelial dysfunction is caused by a disturbance in the balance 
between beneficial NO and harmful ROS in the vascular wall (Feletou and Vanhoutte 
2006; Yung, Leung et al. 2006). ROS are a family of molecules including molecular 
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oxygen and its derivatives produced in all aerobic cells. ROS formation and its 
elimination are kept delicately in balance within vascular wall, so as to maintain 
desirable levels of ROS required for normal physiological function. Enhanced 
activities of oxidant enzymes and/or diminished activities of antioxidant enzymes 
disturb such equilibrium and cause oxidative stress. Physiologically controlled free 
radicals perform beneficial tasks by aiding in the destruction of microorganisms and 
cancer cells (Yung, Leung et al. 2006). Excessive production of ROS, outstripping 
endogenous antioxidant defense mechanisms, has been implicated in processes in 
which they oxidize biological macromolecules, such as DNA, protein, carbohydrates, 
and lipids. This condition has commonly been referred as oxidant stress (Cai and 
Harrison 2000). 
It is of interest that oxidized LDL, but not native LDL, added to isolated 
vessels inhibits endothelium-dependent vascular relaxation (Tanner, Noll et al. 1991; 
Buckley, Bund et al. 1996; Chen, Peng et al.). It is noteworthy that among all the 
oxidized components in oxidized LDL, COPs produced the most adverse effect on the 
endothelium-dependent relaxations in rat aorta (Wong, Ng et al.). In addition, small 
amounts of COPs alone produce significant toxicity to a variety of cell types (Hodis, 
Crawford et al. 1991). There is a strong relationship between plasma and aortic 
arterial wall levels of cholesterol oxides. In addition to exogenous sources, formation 
of cholesterol oxides proceeds via free radical oxidation acting upon elevated 
cholesterol levels resulting in the accumulation of these potentially cytotoxic and 
atherogenic products (Hodis, Crawford et al. 1991). Exposure of the endothelium to 
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elevated levels of LDL cholesterol causes an alteration in endothelial function 
characterized by increased generation of superoxide anion, more rapid degradation of 
NO and, later, reduced synthesis of NO. 
The oxidation of LDL leads to production of linoleic hydroperoxy and alkoxy 
radicals that could participate in such reactions with NO. Recently, it has been shown 
that hydroxyl radical may react with NO (Pieper, Langenstroer et al. 1997). The 
oxidation of cholesterol proceeds as part of the lipid peroxidation process in 
membranes. Small amounts of oxidation products may persist in tissues experiencing 
lipid peroxidation at a low but steady flux of free-radical reactions (Sevanian and 
Peterson 1986). 
Though extensive studies have been performed to investigate the effect of 
oxidized dietary cholesterol on vasculature, there is little information on how oxidized 
dietary phytosterols affect the function of vasculature and the possible toxic effects of 
POPs are still unclear and contradictory. In fact, some studies found that POPs cause 
cytotoxic effect to a variety cell lines but higher concentrations are required to reach 
similar effect to COPs(Adcox，Boyd et al. 2001; Maguire, Konoplyannikov et al. 2003; 
Koschutnig, Heikkinen et al. 2009). Among the oxidation mixture particularly 7-keto-
and 7a-OH-sitosterol showed to be highly active and enhance O2" production 
(Koschutnig, Heikkinen et al. 2009). However, lack of genotoxic effect in vivo of the 
POPs was also reported (Lea, Hepburn et al. 2004; Abramsson-Zetterberg, Svensson 
et al. 2007). In addition, POPs do not promote the development of atherosclerosis in 
apo E deficient mice (Tomoyori, Kawata et al. 2004). 
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1.6 Calcium homeostasis in the vascular smooth muscle cells (VSMCs) 
1.6.1. Modes of Ca2+ entry in VSMC 
Vascular smooth muscle cells (VSMC) are of great importance in controlling 
the contractility of arteries. Entry of Ca^^ into the cytoplasm through membrane Ca^ "" 
channels induces contraction in smooth muscle cells (Yukisada and Ebashi 1961; 
Renter 1983). The level of intracellular Ca^^ is determined by the balance between the 
influx that introduces Ca^^ into the cytoplasm and the efflux that removes Ca^^ from 
the cytoplasm. Several modes of Ca^^ entry have been documented in VSMC; these 
include the Ca^^ influx via voltage-operated Ca^ "" channels (VOCCs), 
receptor-operated Ca^^ channels (ROCCs)，store-operated Ca〗— channels (SOCCs) and 
the reverse mode ofNa^-Ca^^ exchanger (NCX) (Lee, Poburko et al. 2001). 
In VSMC, the major pathway for entry ofCa^"" is mediated by VOCCs (Varadi, 
Mori et al. 1995). VOCCs can be activated by depolarization caused by treatment 
with high-K+ solution; they can also be activated by dihydropyridine Ca^^-channel 
agonists such as Bay K 8644. Electrophysiological and pharmacological studies 
suggested the existence of the six types of VOCCs, namely the L-, T-, N-, R-, Q- and 
P-type (Godfraind and Govoni 1995). In VSMC, L-type and T-type VOCCs are 
present, with L-type being the main type (Hurwitz 1986; Akaike, Kanaide et al. 1989; 
Bean 1989; Kuga，Sadoshima et al. 1990; Pelzer, Pelzer et al. 1990). L-type Ca〗. 
currents, being long lasting, require a strong depolarization for activation, and are 
blocked by the organic L-type Ca^^ channel antagonists, including dihydropyridines, 
phenylalkylamines, and benzothiazepines. T-type Ca^^ currents are activated by weak 
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depolarizations and are transient. They are unaffected by the organic antagonists 
(Ertel, Campbell et al. 2000). 
Except for VOCCs, ROCCs are also one of the common modes ofCa^^ entry in 
VSMC (Lee, Poburko et al. 2001). Compared with VSMC in resistance arteries, aortic 
VSMC are less sensitive to membrane potential and rely on ROCCs to maintain their 
tone (Cauvin, Lukeman et al. 1985; Karaki, Ozaki et al. 1997). A variety of 
vasoconstrictors including a-adrenergic agonists, histamine, and a number of peptides 
can activate ROCCs, and the increase in by ROCCs is responsible for the 
maintenance of tension during the sustained phase of contraction (Goto, Kasuya et al. 
1989). 
SOCCs are Ca^^-permeable channels in the plasma membrane that are open 
upon depletion of intracellular Ca^ "^  stores underlying the so-called "store-operated" 
or "capacitative" Ca^^ entry (Marthan 2004). Single channel currents through SOCCs 
have been recorded in single cells isolated from the aortas of mice and rabbits 
(Trepakova, Gericke et al. 2001). Characterization of SOCCs in smooth muscle is 
complicated owing to the difficulties in recording membrane currents underlying 
store-operated Ca^^ entry in smooth muscle cells (McFadzean and Gibson 2002; 
Albert and Large 2003). In addition, highly selective blockers of SOCCs are still 
lacking. Therefore, an important tool for examining store-operated Ca^^ entry has 
been represented by inhibitors of the SR Ca^^-ATPase pump, such as thapsigargin or 
cyclopiazonic acid (Thastrup, Dawson et al. 1994; Gonzalez De La Fuente, Savineau 
et al. 1995). 
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The NCX, which is present on the plasma membrane of most cells, is a 
transporter catalyzing the counter-transport of Na+ and Ca^ ,^ commonly in ratio of 3 
Na+ for 1 Ca2+. NCX has been detected in a number of VSMC preparations 
(O'Donnell and Owen 1994). Being distinct from other proteins for Ca^^ transport, 
NCX can allow both the increase or the decrease of NCX moves net Ca^^ 
either out of or into cells depending on the prevailing electrochemical driving forces; 
these two modes of NCX are commonly referred as the forward mode and the reverse 
mode, respectively. 
The forward mode of NCX requires the energy of the Na+ gradient produced by 
the Na+/K' -ATPase pump. Although plasmalemmal Na+-Ca2+ exchange system has 
weak affinity for Ca^ ,^ it exhibits a high capacity for Ca〗— transport. Hence, NCX 
eliminates significant rises in Under physiological conditions, Na+enters the 
cell down its electrochemical gradient, releasing energy that fuels the transport of 
^ I 
Ca up its gradient and out of the cell. 
_j_ 2+ 
The Na -Ca exchange system is electrogenic and its activity is therefore 
influenced by the membrane potential (Sheu and Blaustein 1983; Rasgado-Flores and 
Blaustein 1987). As the membrane potential becomes more positive (depolarized), the 
kinetics of the Ca^ "^  efflux becomes slower (Blaustein and Lederer 1999). 
Another feature of the operation of NCX (both the forward and the reverse 
mode) is that it is dependent on the (nontransported) intracellular Ca〗— (Baker and 
McNaughton 1976; DiPolo 1979; DiPolo and Beauge 1987). Only a small fraction of 
the NCX is active at the normal resting [Ca^^]i(~100 nM) in most cells, while it is 
1 7 
fully activated when is in the low micromolar range (Blaustein and Lederer 
1999). The forward mode is activated by internal alkali metal ions and is markedly 
inhibited by high concentrations of internal Na+ (Blaustein and Santiago 1977). In 
contrast to the forward mode, the reverse mode requires extracellular Ca^ "^  for 
activation (Blaustein and Santiago 1977; DiPolo and Beauge 1990). Nickel is a 
common unspecific NCX blocker (Perchenet, Hinde et al. 2000) and is also employed 
in the present study to investigate the involvement of NCX. 
1.6.2 Modes ofCa^^ efflux in VSMC 
Apart from the forward mode of NCX, the declining of cytosolic Ca^^ also 
depends on sarcoplasmic/endoplasmic reticulum Ca^^-ATPase (SERCA) and plasma 
membrane Ca^^-ATPase (PMCA) (Lee, Poburko et al. 2001). SERCA is a Ca^^ pump 
that transfers Ca^ "^  from the cytosol to the lumen of the SR/ER using the energy 
produced by ATP hydrolysis (de Meis 2002; Kubala 2006). Thapsigargin, the SERCA 
inhibitor, exhibits highly selective inhibitory effect on SERCA in the nanomolar 
concentration range (Thastrup, Cullen et al. 1990; Wootton and Michelangeli 2006). 
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Figure 1.4 illustrates the major proteins responsible for regulating Ca^^ influx 
and removal in VSMC. 
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Figure 1.4 Major proteins responsible for regulating Ca^ "^  influx and removal in 
VSMC. On the plasma membrane, the entry modes of Ca^^  channels, including 
VOCC, ROCC, SOCC, and reverse mode of NCX, allow Ca^^ influx from external 
solution to cytosol; while PMCA and NCX remove cytosolic Ca〗. to external 
environment. SERCA on ER pumps cytosolic Ca^^ back to ER. 
1.7 Objectives of the study 
We hypothesized that the P-sitosterol oxidation products (SOPs) impaired the 
function of rat aorta with intact endothelium while the native form of phytosterols, e.g. 
3-sitosterol, stigmasterol and brassicasterol could protect the endothelial function of 
aorta against oxidative stress. In addition, the effect of SOPs on the function of rat 
aorta VSMC was also examined. The specific aims of this project were: 
1 9 
1) To investigate the effects of SOPs and p-sitosterol on endothelium-dependent 
relaxations in rat aorta (chapter 2); 
2) To investigate the mechanisms underlying the effects of SOPs and/or 
3-sitosterol on endothelium-dependent relaxations in rat aorta (chapter 2); 
3) To investigate the effects of SOPs and p-sitosterol on the contractility of 
endothelium-denuded rat aorta (chapter 3); 
4) To investigate the effects of SOPs and/or P-sitosterol on the activity of 
various calcium regulatory proteins in the vascular smooth muscle of 
endothelium-denuded rat aorta (chapter 3); 
5) To investigate the effect of P--sitosterol, brassicasterol and stigmasterol on 
impaired endothelium-dependent relaxations in rat aorta (chapter 4); 
6) To investigate the mechanisms underlying the rescuing effects of phytosterols 
on impaired endothelium-dependent relaxations in rat aorta (chapter 4). 
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Chapter Two P-Sitosterol Oxidation Products Attenuate Vasorelaxation by 
Increasing Reactive Oxygen Species and Cyclooxygenase-2 
2.1 Introduction 
Phytosterols, the membrane constituents of plants, are present at high 
concentrations in vegetable oils, nuts, seeds and grains. Phytosterols are structurally 
similar and functionally analogous to cholesterol (Hovenkamp, Demonty et al. 2008; 
Clifton 2009). Phytosterols can lower blood cholesterol by reducing the absorption of 
cholesterol (Clifton 2009; Demonty, Ras et al. 2009), which is one of major risk 
factors for the development of cardiovascular diseases (Gordon, Probstfield et al. 
1989; Klag, Ford et al. 1993; Barter, Gotto et al. 2007; Kathiresan, Melander et al. 
2008). Previous studies suggested that a daily intake of 1.5-3 g phytosterols could 
reduce 9-15% of serum low density lipoprotein cholesterol level (Weststrate and 
Meijer 1998; Hendriks, Weststrate et al. 1999; Law 2000; Clifton 2002). Due to this 
health benefit, phytosterols have been used in the production of various functional 
foods (Katan, Grundy et al. 2003; Clifton, Noakes et al. 2004; Clifton 2009; 
Koschutnig, Heikkinen et al. 2009). Among different phytosterols, the most abundant 
one in nature is P-sitosterol (Weihrauch and Gardner 1978; Dutta 1999; Gotor , Farkas 
et al. 2007). P-sitosterol shares the four-ring structure common to cholesterol and 
differs from cholesterol by having an extra ethyl group attached at C-24 (Hovenkamp, 
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Demonty et al. 2008). 
Due to the structural similarity, phytosterol is likely to be as susceptible as 
cholesterol to oxidation. Previous studies showed that phytosterol oxides are formed 
when plant oils are subjected to heat treatment or under long-term storage (Dutta and 
Appelqvist 1997; Hovenkamp, Demonty et al. 2008). Phytosterols can undergo 
oxidation in food-processing conditions, generating 7-hydroxysterols, 7-ketosterols, 5, 
6-epoxysterols, triols, and 25-hydroxysterols as the major oxidation products (Lampi, 
Juntunen et al. 2002; Bortolomeazzi, Cordaro et al. 2003; Apprich and Ulberth 2004; 
Hovenkamp, Demonty et al. 2008). The amount of phytosterol oxides in vegetable 
oils increases after frying for 2 days (Dutta and Appelqvist 1997) and French fries 
fried in vegetable oil was reported to contain higher concentrations of phytosterol 
oxides than those before frying (Grandgirard 2002). Apart from oils after frying, 
commercially available phytosterol-enriched margarine contains -0.1% of phytosterol 
oxides (Grandgirard 2002). With a daily intake of 2-4 g phytosterols, it is estimated 
that 2-4 mg phytosterol oxides could be ingested (van de Bovenkamp, 
Kosmeijer-Schuil et al. 1988; Lake and Scholes 1997). In fact, this quantity of 
phytosterol oxides ingested is similar to the quantities of cholesterol oxidation 
products (COPs) (3-4 mg) presented in the daily diets of people as documented in a 
study in the Netherlands and New Zealand (Tomoyori, Kawata et al. 2004). In 
addition, phytosterol oxides are well-absorbed and can accumulate in the body 
(Grandgirard 2002), and phytosterol oxides are present in the plasma from both healthy 
human subjects (Plat, Brzezinka et al. 2001; Grandgirard, Martine et al. 2004) and 
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phytosterolaemic patients (Plat, Brzezinka et al. 2001). 
Given that P-sitosterol is the most abundant phytosterol and that P-sitosterol 
exhibits similar oxidation pattern as that of cholesterol in terms of oxidation products 
(Hovenkamp, Demonty et al. 2008; Xu, Guan et al. 2009), both P-sitosterol oxidation 
products (SOPs) and COPs are important constituents of our daily diets. Several studies 
investigated the effect of COPs on the vascular function. 7-ketocholesterol induces 
apoptosis in rabbit vascular smooth muscle cells (Nishio, Arimura et al. 1996) and 
7p-hydroxycholesterol and 7-ketocholesterol cause cell death and apoptosis versus 
necrosis in cells of the human vascular wall (Lizard, Monier et al. 1999). Our recent 
investigation also reports that COPs attenuate endothelium-dependent relaxation of rat 
aortas (Wong, Ng et al.). 
However, little is known about the effects of SOPs and P-sitosterol on the 
functionality of blood vessels. The main objective of this study was therefore to 
examine the effects of SOPs and P-sitosterol on endothelium-dependent relaxation and 
the possible cellular mechanisms involved. 
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2.2 Materials and methods 
2.2.1 Preparation of SOPs 
SOPs were prepared by heat treatment. Briefly, 4 mL of p-sitosterol dissolved 
in chloroform at 100 mg/mL was uniformly distributed in the Petri dish and heated in 
the oven at 180。匸 for 35 minutes. A mixture of P-sitosterol and SOPs was obtained. 
The mixture was further separated by silica gel chromatography. 
2.2.2 Gas chromatography -mass spectrometry (GC-MS) identification of SOPs 
Each fraction separated by silica gel chromatography was detected by GC-MS. 
Identification of p-sitosterol and their oxides was carried out on a 6890 series gas 
chromatograph coupled with an Agilent 5973 mass spectrometer (Agilent 
Technologies Inc., Palo Alto, CA) with a full scan mode {m/z 45-600). Similarly, the 
trimethylsilyl (TMS) derivatives of SOPs were separated on a SAC-5 column. Helium 
was used as a carrier gas at a constant flow of 1.0 mL/min. The column temperature 
was programmed from 90 to 270 "^C at a rate of 30 /min and then to 300 at 1.5 
/min, at which it was held for 12 min. The MS interface temperature was 280 "^ C, 
and the ion source was 230 Electron ionization energy was set at 70 eV. Individual 
SOPs were identified according to their retention times of authentic standards and 
specific characteristics of mass spectra ions as previously published (Petron, 
Garcia-Regueiro et al. 2003; Zhang, Julien-David et al. 2005; Mariutti, Nogueira et al. 
2008). 
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2.2.3 Analyses of SOPs 
SOPs were quantified in a Shimadzu GC-2010 gas-liquid chromatograph 
equipped with a flame ionization detector and an automated injector (Tokyo, Japan). 
Briefly, 40 |ig of 5a-cholestane in ethyl acetate as an internal standard was added into 
each sample. After the removal of ethyl acetate under a gentle stream of nitrogen, 100 
|liL ofTMS reagent was added to derivatize SOPs at 60 for 60 min. The TMS-ether 
derivatives were dissolved into 400 |LIL of hexane with 1 |LIL being injected onto a 
fused silica capillary column (SAC-5, 30 m x 0.25 mm, i.d.; Supelco). Helium was 
used as a carrier gas at a constant flow of 1.0 mL/ min. Column temperature was 
programmed from 90 to 270 at a rate of 30 ^C /min and then to 300 ^C at 1.5 
/min, at which it was held for 12 min. Both injector and detector temperatures were 
set at 300 SOPs were quantified according to the amount of internal standard 
added. 
2.2.4 Vessel preparation 
This study was approved by the Animal Ethics Committee, Chinese University 
of Hong Kong and conformed to Guide for the Care and Use of Laboratory Animals 
published by the United States National Institutes of Health (NIH Publication No. 
85-23, revised 1996). Male Sprague-Dawley rats (260-280 g) were euthanized by 
CO2 inhalation. The thoracic aorta was dissected out, removed of adhering connective 
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tissues, and cut into ring segments of around Smm-wide. As described (Huang, Chan 
et al. 1999), each ring was suspended between two stainless wire hooks in a 10 mL 
organ chamber filled with Krebs solution containing (in mM): 119 NaCl, 4.7 KCl, 25 
NaHCOs, 2.5 CaCls, 1 MgCb, 1.2 KH2PO4, and 11 D-glucose. The upper wire was 
connected to a force-displacement transducer (Grass Instruments, RI, USA) and the 
lower one was fixed to the bottom of the organ bath. The bathing solution was 
oxygenated by 95% O2 and 5% CO2 and maintained at 37 °C (pH 7.4). Rings were 
allowed to equilibrate for 30 minutes before being adjusted to an optimal resting 
tension of 25 mN. In some rings, the endothelial layer was mechanically disrupted by 
very gently rubbing the luminal surface of the artery with forceps. 
2.2.5 Isometric force measurement 
Isometric tensions were recorded with force transducer connected to a Maclab 
analogue-to-digital converter system. Thirty minutes after mounting in organ baths, 
all rings were first contracted by 60 mM K+ to test their contractile capacity. After 
washing twice, the rings were then contracted by 0.3 | iM phenylephrine followed by 
addition of 3 juM acetylcholine (ACh) to test the integrity of the endothelium (over 
80% relaxation) or functional removal of the endothelium (no relaxation). Al l rings 
were subsequently rinsed in pre-warmed, oxygenated Krebs solution several times 
until baseline tone was restored and allowed to equilibrate for 30 minutes. Each 
experiment was carried out on rings prepared from different rats. Drugs or solvent, 
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when used, were incubated with rings for either 30 minutes or 2 hours depending on 
experiments prior to addition of phenylephrine. 
2.2.6 Western blotting 
Isolated aortas were incubated with SOPs (30 jig/ml) or solvent. Some rings 
were pre-treated with tempol (30 [iM) before exposure to SOPs. After treatment, rings 
were frozen in liquid nitrogen and stored at -80 for later processing. The rings 
were homogenized with ice-cold RIPA lysis buffer (PBS containing 1% NP-40, 0.5% 
sodium deoxycholate, 1% SDS) supplemented with 1% protease inhibitor cocktail 
[leupeptin (1 |ig/mL), aprotinin (5 |ig/mL), PMSF (100 |ig/mL), sodium 
orthovanadate (100 |ig/mL), EGTA (200 ^ig/mL) and EDTA (200 ^ig/mL)] and 
phosphatase inhibitor cocktail [NaF (250 mM), P-glycerolphosphate (500 \ig/mL) and 
HEPES (50 mM, pH 7.3)]. The lysates was then centrifuged at 16,000 g, 4 for 20 
minutes. Supernatant was collected and protein concentration was determined by 
Bradford Assay (Bio-Rad Laboratories). One volume of 2x gel loading buffer 
containing 10% P-mercaptoethanol was added and the samples were denatured by 
boiling for 10 minutes. Equal amount of total protein was separated under reducing 
conditions on a 7.5% SDS-polyacrylamide gel. Pre-stained Novex Sharp Standard 
marker (Invitrogen) was loaded in parallel as a standard molecular weight marker. The 
resolved proteins were electroblotted to immobilon-P polyvinylidene difluoride 
(PVDF) membrane (Millipore) using wet transfer at 110 V for 80 minutes at 4。C. The 
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membranes were blocked with 5% non-fat milk for 1 hour at room temperature. Blots 
were incubated with primary antibody against COX-1 (mouse monoclonal, 1:500, 
Cayman) or COX-2 (rabbit polyclonal, 1:300, Cayman) overnight at 4。C in 5% 
non-fat milk. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:10000, 
Ambion) was used as a housekeeping protein. After washing with TEST, blots were 
incubated with horseradish peroxidase-conj ugated secondary antibodies (rabbit 
anti-mouse and goat anti-rabbit antibodies, Dako) at a dilution of 1:5000 in 5% 
non-fat milk for 1 hour at room temperature. The membranes were developed with an 
enhanced chemiluminescence detection system (Western lighting plus-ECL; 
PerkinElmer, USA) and then exposed to X-ray films (Fuji). The signal intensities 
were quantified using AlphaEase software of the FluorChemTM 8000 digital gel 
documentation system (Alpha Innotech Corp.). For each experimental group, signal 
intensity of the target protein will first be normalized to that of the housekeeping 
protein GAPDH. The value obtained from treatment group wil l then be normalized to 
that of the control group. 
2.2.7 Primary culture of rat aortic endothelial cell 
Endothelial cells were cultured from rat thoracic aortas as described (Huang, 
Chan et al. 1999). Briefly, the aorta was placed in ice-cold sterile PBS and trimmed of 
periadventitial adipose tissues. After cutting open longitudinally, the artery was 
subjected to digestion in 0.2% collagenase (Type lA; Sigma) for 15 minutes at 37。(：. 
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The cell suspension was centrifuged at 800 g for 10 minutes and then re-suspended in 
RPMI 1640 supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S) (GIBCO). Medium was changed after settling for 1 hour. 
Identity of the endothelial cells was previously validated by a positive staining of the 
endothelial cell specific marker, platelet/endothelial cell adhesion molecular-1 
(PECAM-1). 
2.2.8 Measurement of SOPs-induced intracellular oxidative stress 
Intracellular level of reactive oxygen species (ROS) in primary rat aortic 
endothelial cells were determined by dihydroethidium (DHE) (Molecular Probes) 
fluorescence emitted upon oxidation. Endothelial cells were seeded on coverslips at 
〜60-70% confluence and incubated with SOPs (30 |Lig/mL) for 10, 15, 30, 45 or 60 
minutes for determination of the peak ROS level stimulated by SOPs. In another set 
of experiments, cells were pre-incubated with a ROS scavenger, tempol, for 30 
minutes before 15 minutes-incubation with SOPs. Cells were rinsed with normal 
physiological saline solution (NPSS in mM, 140 NaCl, 5 KCl, 1 CaCl2, 1 MgCl〕，10 
glucose, 5 HEPES, pH 7.4) after the treatments and incubated in 5 jiiM DHE for 20 
minutes at 37 in dark. After a rinse in NPSS, fluorescence was observed under a 
confocal microscope (Olympus Fluoview) with 515-nm excitation and filtered 
through a 585-nm long pass filter. DHE fluorescence intensity was analyzed by 
Fluoview (version 1.5; FV10-ASW1.5) and the data were expressed in fold change 
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compared with control treated with vehicle (final concentration of 0.1% ethanol). 
2.2.9 Drugs 
Phenylephrine and indomethacin were purchased from RBI (Natick, MA 
USA). ACh, 5a-cholestane, 7a-hydroxycholesterol, 7p-hydroxycholesterol, 
5,6p-epoxycholesterol, 5,6a-epoxy cholesterol, 7-ketocholesterol, quercetin, 
trimethylsilyl (TMS) reagent, diphenylene iodonium (DPI) and oxypurinol were 
purchased from Sigma (St. Louis, MO, USA). A23187, SC560, DuP-697 were 
purchased from Tocris (Bristol, UK). P-sitosterol was purchased from Meihe 
Company (Shenzhen, China). S18886 was a kind gift from Institut de Recherches 
Servier (Suresnes, France). SOPs were made by our team as described above. 
Indomethacin, A23187, SC 560, DuP 697, DPI and SI8886 were dissolved in 
dimethyl sulfoxide (DMSO) as stock solution, P-sitosterol and SOPs were dissolved 
in ethanol (100%), oxypurinol was dissolved in 5% NaOH and all other drugs were 
dissolved in double-distilled water. Stock solutions were stored at -20 Desired 
dilution was prepared in Krebs solution shortly before experimentation. DMSO or 
ethanol at 0.2% did not influence vessel tone. 
2.2.10 Data Analysis 
Data are mean 士 SEM of n rings from different rats. pECso is the negative 
logarithm of the drug concentration needed to cause 50% of the maximal response 
(relaxation or contraction) (Emax) as determined by non-linear regression curve fitting 
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(Graphpad Prism Software, version 5.0). Student's t-test (two-tailed) was used when 2 
groups of means were compared. One-way ANOVA followed by the Bonferroni post 




2.3.1 GC-MS identification of SOPs 
SOPs standards are not commercially available, so the analytical methods for 
SOPs have been carried out using commercial COPs as model substances, assuming 
that the ionization efficiency of both types of molecules and their behavior are very 
similar due to their structural similarity. Previous studies showed that response factors 
obtained for COPs are also valid for quantitative work regarding phytosterol oxidation 
products (POPs) (Lampi, Juntunen et al. 2002; Menendez-Carreno, Garcia-Herreros et 
al. 2008; Xu, Guan et al. 2009). 
SOPs were identified by both relative retention times and mass spectra data 
of TMS ethers derivates of SOPs as demonstrated in Table 2.1. The characteristic ions 
in bolds indicate those used for the qualitative analysis in the selected ion monitoring 
(SIM) spectra. The ions identified for each SOPs were compared with COPs 
standards and also previously published spectra (Lampi, Juntunen et al. 2002; 
Menendez-Carreno, Garcia-Herreros et al. 2008). Relative retention times in relation 
to 5a-cholestane are also shown in Table 2.1. 
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Table 2.1 
Characteristic ions and relative retention times of SOPs and COPs standards 
Oxysterols Characteristic ions {m/z) Relative retention times 
7a-hydroxycholesterol 456 1.291 
7a-hydroxysitosterol 484 1.543 
7p-hydroxycholesterol 456 1.460 
7p-hydroxysitosterol 484 1.740 
5,6a-epoxycholesterol 384 474 1.502 
5,6a-epoxysitosterol 412 502 1.815 
5,6p-epoxycholesterol 384 474 1.528 
5,6p-epoxysitosterol 412 502 1.847 
7-ketocholesterol 367 472 1.751 
7-ketositosterol 395 500 2.139 
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2.3.2 Analyses of SOPs 
The amounts of each SOPs were quantified by GC according to the amount 
of internal standard added and the area of individual peak (Figure 2.1). The order of 
elution of SOPs followed the sequence 7a-hydroxy, 7p-hydroxy, 5,6a-epoxy, 
5,6p-epoxy, and 7-keto oxyderivates for every compound as demonstrated in Figure 
2.1. The amount of 7-ketositosterol (peak 6) is the highest in SOPs, accounting for 
41.8% of the total components. 7a-hydroxysitosterol (peak 2), 7P-hydroxysitosterol 
(peak 3), 5,6a-epoxysitosterol (peak 4) and 5,6p-epoxysitosterol (peak 5) accounted 
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Figure 2.1 GC spectrum of the main SOPs. 1: 5a-cholestane (internal standard); 2: 
7a-hydroxysitosterol; 3: 7p-hydroxysitosterol; 4: 5,6a-epoxysitosterol; 5: 
5,6P-epoxysitosterol; 6:7-ketositosteroL 
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2.3.3 SOPs but not P-sitosterol impaired ACh- and A23187-induced relaxations 
Treatment with SOPs for 30 minutes attenuated ACh-induced 
endothelium-dependent relaxation in a concentration-dependent manner (Figure 2.2A, 
Table 2.2). Prolonged incubation (120 minutes) with SOPs did not cause further 
impairment in ACh-induced relaxation (Figure 2.2B, Table 2.2). Likewise, SOPs also 
reduced A23187-induced relaxations in aortas with endothelium (Figure 2.2C, Table 
2.2). By contrast, the concentration-dependent relaxations to ACh were not affected 
by P-sitosterol (Figure 2.2D). 
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Figure 2.2 
A) ACh-induced relaxation when the rat aortas were incubated with different 
concentration of SOPs (1 jug/mL - 30 |Lig/mL) for 30 minutes (n=5-7). SOPs 
attenuated ACh-induced relaxation in a concentration-dependent manner. 
B) ACh-induced relaxation in the absence (n=9) or presence of SOPs (30 |ug/mL) 
(n=7) for 2 h. Prolonging the incubation time of SOPs from 30 minutes to 2 hours 
did not further attenuate ACh-induced relaxation. 
C) A23187-induced relaxation in the absence (n=6) or presence of SOPs (30 jug/mL) 
(n=8) for 30 minutes. SOPs attenuated A23187-induced relaxation. 
D) ACh-induced relaxation when the rat aortas were incubated with different 
concentration of P-sitosterol (1 jug/mL — 30 |Lig/mL) for 30 minutes (n=4-7). 
3-sitosterol did not affect ACh-induced relaxation. 
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2.3.4 Inhibition of COX pathway reversed SOPs-induced impairment in 
relaxation 
Treatment with indomethacin (1 |LIM), a non-selective COX inhibitor, rescued 
the SOPs-impaired relaxation (Figure 2.3A, Table 2.2). Further examination showed 
that DuP-697 (a selective COX-2 inhibitor, 0.3 |LIM) completely restored the 
SOPs-induced impairment in relaxation (Figures 2.3B, Table 2.2). In contrast, SC-560 
(a selective COX-1 inhibitor, 0.3 [iM) only slightly alleviated the impaired relaxation 
(Figures 2.3C, Table 2.2). SI8886 (0.1 JIM), a thromboxane-prostanoid (TP) receptor 
antagonist, also normalized the SOPs-induced inhibition of ACh-induced relaxation 
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Figure 2.3 
A) Effect of indomethacin (1 |iM) on SOPs-induced impairment on ACh-induced 
relaxations (n=6-7). Indomethacin reversed the effects of SOPs, suggesting that 
SOPs acted through a COX-mediated pathway. 
B) Effect of DuP-697 (0.3 ^iM) on SOPs-induced impairment on ACh-induced 
relaxations (n=7). DuP-697 completely reversed the effects of SOPs, suggesting 
that SOPs acted through a COX-2-mediated pathway. 
C) Effect of SC-560 (0.3 |LIM) on SOPs-induced impairment on ACh-induced 
relaxations (n=4-7). SC-560 partially reversed the effects of SOPs, suggesting that 
SOPs partially acted through a COX-1-mediated pathway. 
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D) Effect of SI8886 (0.1 ^iM) on SOPs-induced impairment on ACh-induced 
relaxations (n=4-7). SI8886 completely reversed the effects of SOPs, suggesting 
that SOPs acted through a TP receptor-mediated pathway. 
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2.3.5 SOPs elevated endothelial COX-2 expression 
Western blot analysis showed that SOPs increased the COX-2 expression in 
aortas with endothelium (1.77 士 0.30 vs 1.00 士 0.23 in control group, P<0.05) (Figure 
2.4A). On the contrary, SOPs did not alter COX-1 expression (0.96 士 0.06 vs 1.00 士 
0.06 in control group) (Figure 2.4B). Endothelium removal inhibited the 
SOPs-induced up-regulation of COX-2 (0.74 士 0.17 vs 0.88 士 0.23 for 
endothelium-denuded group without SOPs vs endothelium-denuded group with SOPs, 
尸>0.05) (Figure 2.4C). 
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Figure 2.4 
A) (Upper panel) Representative blots showing the effects of SOPs treatment on the 
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expression of COX-2 in endothelium-intact aortas; (Lower panel) Western blot 
analysis showing the expression of COX-2 after SOPs treatment. SOPs 
up-regulated COX-2 expression. GAPDH was used as the control loading protein. 
Values are mean 士 SEM of 6 experiments. *户<0.05 vs control group. IDV, 
integrated density value. 
B) (Upper panel) Representative blots showing the effects of SOPs treatment on the 
expression of COX-1 in endothelium-intact aortas; (Lower panel) Western blot 
analysis showing the expression of COX-1 after SOPs treatment. SOPs did not 
affect COX-1 expression. GAPDH was used as the control loading protein. Values 
are mean 士 SEM of 12 experiments. IDV, integrated density value. 
C) (Upper panel) Representative blots showing the effects of SOPs treatment on 
expression of COX-2 in endothelium-intact and endothelium-denuded aorta; 
(Lower panel) Western blot analysis showing the expression of COX-2 after SOPs 
treatment in endothelium-intact and endothelium-denuded aorta. SOPs treatment 
did not alter COX-2 expression in endothelium-denuded aorta (n=7). GAPDH was 
used as the control loading protein. Values are mean 士 SEM of 7 experiments. 
*P<0.05 vs endothelium-intact group without SOPs; #户<0.05 vs 
endothelium-denuded group with SOPs. IDV, integrated density value. 
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2.3.6 SOPs increased COX-2 expression via an oxidative stress-sensitive pathway 
SOPs (30 |Lig/mL) induced an early-on elevation in intracellular oxidative 
stress as reflected by a significant increase in DHE fluorescence in cells treated with 
SOPs for 10 minutes (Figure 2.5A). This SOPs-stimulated ROS level peaked at 15 
minutes (Figure 2.5A), which was inhibited by the superoxide dismutase mimetic 
tempol (Figure 2.5B). Tempol and tiron (free radical scavenger) also completely or 
partially reversed the attenuated ACh-induced relaxation in SOPs-treated aortic rings 
with endothelium (Figures 2.5C & D, Table 2.2). In addition, the impairment of 
ACh-induced relaxation by SOPs treatment was restored by DPI (NADPH oxidase 
inhibitor, Figure 2.5E, Table 2.2) and oxypurinol (xanthine oxidase inhibitor, Figure 
2.5F, Table 2.2). 
To further investigate the possible association between SOPs-induced 
up-regulation of COX-2 and stimulated ROS production, western blotting was 
performed to determine whether tempol could reverse the up-regulation of COX-2 
induced by SOPs. Indeed, tempol normalized the SOPs-induced up-regulation of 
COX-2 expression (0.82 士 0.02 vs 1.52 士 0.18 for SOPs and tempol-cotreated group 
vs SOPs-treated group,尸<0.05) (Figure 2.6). 
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Figure 2.5 
A) Representative images showing the effect of SOPs (30 |Lig/mL) on the intracellular 
oxidative stress level in rat aortic endothelial cells as detected by DHE; 
Summarized data on the effects of SOPs (30 |ig/mL) on the intracellular oxidative 
stress level in rat aortic endothelial cells. SOPs increased the intracellular 
oxidative stress level as reflected by a significant increase in DHE fluorescence 
with the ROS level peaked at 15 minutes. *** P<0.001 vs control. Values are 
mean 士 SEM of 4-10 experiments. 
B) DHE fluorescence was elevated with 15-minutes incubation of SOPs (30|ig/mL) 
and was reversed by the ROS scavenger tempol in rat aortic endothelial cells. The 
results suggested that SOPs elevated the intracellular oxidative stress level. 
C) Effect of tempol on SOPs-induced impairment on ACh-induced relaxations 
(n=5-12). Tempol totally reversed the effects of SOPs, suggesting that oxidative 
stress exerted by SOPs was involved in the attenuation of endothelium-dependent 
relaxation. 
D) Effect of tiron on SOPs-induced impairment on ACh-induced relaxations (n=3). 
Tiron partially reversed the effects of SOPs, suggesting that oxidative stress 
exerted by SOPs was involved in the attenuation of endothelium-dependent 
relaxation. 
E) Effect of DPI on SOPs-induced impairment on ACh-induced relaxations (n=4). 
DPI completely reversed the effects of SOPs, suggesting that oxidative stress 
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exerted by SOPs may origin from NADPH oxidase. 
F) Effect of oxypurinol on SOPs-induced impairment on ACh-induced relaxations 
(n=4). Oxypurinol totally reversed the effects of SOPs, suggesting that oxidative 
stress exerted by SOPs may also relate to xanthine oxidase. 
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Figure 2.6 
(Upper panel) Representative blots showing the effect of tempol treatment on 
SOPs-induced COX-2 up-regulation in rat aorta; (Lower panel) Western blot analysis 
showing co-treatment with tempol and SOPs could reverse the up-regulation of 
COX-2 induced by SOPs in endothelium-intact aorta. GAPDH was used as the 
control loading protein. Values are mean 士 SEM of 4-10 experiments. ** P<0.01 vs 
control; #P<0.05 vs SOPs. IDV, integrated density value. 
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Table 2.2 
pECso and Emax (%) of various treatment on endothelium-dependent vasorelaxation. 
Treatment pECsp Emax n 
ACh-induced relaxation after 30-min treatment with SOPs 
^ h a n o l control | 7.01 士 0.06 90.76 ±1.93 7 
1 |ig/mL 6.86 士 0.07 80.91 士 3.46* 6 
10 ^ig/mL 6.70 士 0.15 79.11 + 7.29 5 
30 |ig/mL _6.65 士 0.08** 78.64 ±3.15** “ 7 
ACh-induced relaxation after 2h-treatment with SOPs 
"i^hanol control 6.93 士 0.04 92.73 士 1.73 9 
30 |Lig/mL -6.58 士 0.08*** 78.85 士 3.85** 7 
A23187-induced relaxation after 30-min treatment with SOPs 
^ h a n o l control 7.94 ±0.13 | 93.46 士 1.09 6 
" ^ P s 30 ^g/mL ^ 4 5 ±0.13* 87.51 士 1.99* 1 ^  
ACh-induced relaxation after 30-min treatment with p-sitosterol 
^ a n o l control (10 |iL) 6.96 士 0.05 91.77 ± 1.83 10 
P-sitosterol 1 |ag/mL 6.70 士 0.14 95.07 土 7.18 4 _ 
p-sitosterol 10 |ig/mL 6.90 士 0.10 88.49 ± 1.56 4 
Ethanol control (30 |iL) 6.94 士 0.06 94.75 士 1.20 7__ 
p-sitosterol 30 jiig/mL 6.83 士 0.12 91.84 ±4.60 5 
ACh-induced relaxation after drug treatment for 30 min 
" ^ P s 30 |Lig/mL 6.65 士 0.08 78.64 士 3.15 “ 7 
" ^ P s 30 lug/mL + indomethacin 1 ^ iM "7.01 士 0.08## 90.40 士 3.92# 7 
" ^ P s 30 |ig/mL + SC-560 0.3 | iM -7.OO 士 0.11# 78.55 士 8.20 “ 4 
30 |ig/mL + DuP-697 0.3 [iM T q 3 士 0.09## 92.12 士 2.79湘 
30 ^g/mL + SI8886 0.1 | iM 7.08±0.12## 93.05 ±4.63# 4 
SOPs 30 |Lig/mL (vs SOPs+Tempol) 6.66 ±0.06 73.20 ±3.17 12 
30 iiig/mL + tempol 30 ^iM 6.91±0.07# 86.14士 1.93## “ 5 
Ethanol control 6.95 士 0.09 102.95 士 1.51 3 
SOPs 30 |ig/mL 6.66 土 0.14 " ^ 1 3 士 4.00** 4 
SOPs 30 ng/mL+ Oxypurinol 30 |LIM 6.85 士 0.09 95.84 ±2.71## 4 
SOPs 30 |Lig/mL+ tiron 100 mM 6.75 ± 0.08 士 1.96# 3 
30 ng/mL+ DPI 1 nM 7.10 士 0.07# 91.66 士 2.74# 4 
Significant difference between control and treatment groups is indicated by *P<0.05, 
**尸<0.01, ***P<0.001 vs solvent control; #P<0.05, ##尸<0.01 vs SOPs 30 |Lig/mL. 
Data are means 士 SEM of n experiments. 
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2.4 Discussion 
Main findings of the present investigation include: 1) SOPs but not 
P-sitosterol attenuated endothelium-dependent relaxation; 2) SOPs-mediated 
attenuation of endothelium-dependent relaxation was reversed by inhibiting COX-1 or 
COX-2 and by scavenging ROS production; 3) SOPs increased ROS production in the 
endothelial cells; 4) SOPs increased the expression of COX-2 protein in the 
endothelium which was reversed by scavenging ROS production. 
180®C was selected as a heating temperature for the preparation of SOPs 
because it is a typical frying temperature (Xu, Guan et al. 2009) and therefore SOPs 
produced by this way is common in daily life. For the first time, the present study 
demonstrated the effect of SOPs and P-sitosterol on the functionality of arteries. SOPs, 
but not P-sitosterol, were found to impair endothelium-dependent relaxation. Indeed, 
previous reports suggested that the oxidized forms of phytosterols or cholesterol were 
more cytotoxic than the non-oxidized form to various cell lines (Steinberg, 
Parthasarathy et al. 1989; Sevanian, Hodis et al. 1995). SOPs increased superoxide 
anion production(Koschutnig, Heikkinen et al. 2009) and decreased cellular 
glutathione. This reduction in glutathione was accompanied by an increase in 
apoptosis which was not observed when cells were subjected to P-sitosterol treatment 
(Maguire, Konoplyannikov et al. 2003). These studies suggested that the oxidized 
forms of P-sitosterol, but not P-sitosterol per se, can produce oxidative stress and lead 
to detrimental cellular effects. Consistently, the present study showed that SOPs 
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increased the ROS level in endothelial cells. In addition, SOPs attenuated 
endothelium-dependent relaxation which was reversed by ROS scavenger, suggesting 
that SOPs mediate their effect through exerting oxidative stress. Interestingly, both 
DPI (a NADPH oxidase inhibitor) and oxypurinol (a xanthine oxidase inhibitor) 
completely reversed the effects of SOPs on attenuating the ACh-induced relaxation, 
suggesting that SOPs may generate ROS via stimulating NADPH oxidase and/or 
xanthine oxidase. The ROS generated by SOPs may react with nitric oxide and 
decrease the bioavailability of nitric oxide, leading to the reduced 
endothelium-dependent relaxation. 
The concentrations of SOPs used in the present in vitro study are higher than 
those experienced in vivo (Grandgirard, Martine et al. 2004). However, worth to note, 
they are in the range of the concentrations used in many of the other in vitro studies in 
the literature (Wong, Ng et al. ； Deckert, Persegol et al. 1997). In addition, the 
exposure times used in the present study are much shorter than those experienced in 
animal models (Liang Y.T. 2011). The use of higher pharmacological concentrations is 
required in the present in vitro study to mimic the in vivo situation for us to 
investigate possible mechanism(s) of SOPs-induced endothelial dysfunction. 
Previous studies showed that in hypertensive patients, vasodilation was 
impaired in the presence of COX-derived vasoconstrictor(s), such that infusion of 
indomethacin improved the acetylcholine-induced relaxation significantly (Versari, 
Daghini et al. 2009). Similarly, in our present investigation, endothelium-dependent 
relaxation is employed as the parameter to test for the impact of SOPs on endothelial 
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function. In this study, indomethacin, a non-selective COX inhibitor, was found to 
reverse the attenuated endothelium-dependent relaxations by SOPs. Notably, COX-2 
inhibitor completely abolished the impact of SOPs while the effect of COX-1 
inhibitor was partial, indicating that SOPs may possibly attenuate relaxation by 
prostanoids mainly derived from COX-2. Western blotting showed that SOPs 
treatment increased endothelial COX-2 expression. Liu et al. (2009) demonstrated 
that TP receptor activation impairs cAMP-dependent relaxations (Liu, Leung et al. 
2009). Similarly, SI8886, a TP receptor antagonist, completely normalized the effect 
of SOPs, indicating that the SOPs-induced inhibition on endothelium-dependent 
relaxation is also mediated by TP receptor. Taken together, it is likely that SOPs 
enhanced the expression of endothelial COX-2, resulting in the production of 
vasoconstrictors which can act on the TP receptor to attenuate the 
endothelium-dependent relaxations. The present findings showed that the increased in 
COX-2 expression by SOPs was reversed by scavenging ROS, suggesting that SOPs 
increased ROS production which in turn increased endothelial COX-2 expression. 
These results are in line with previous studies showing that COX-2 expression is 
sensitive to oxidative stress in endothelial cells (Wong, Tian et al.). Therefore, ROS 
can, on the one hand, act directly to attenuate endothelium-dependent relaxation. On 
the other hand, ROS may indirectly attenuate endothelium-dependent relaxation by 
increasing the COX-2 expression and subsequently higher levels of vasoconstrictors 
which activate TP receptors, in addition to its well-documented nitric oxide 
scavenging effect. 
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Endothelium dysfunction was found to be associated with the pathogenesis of 
a number of cardiovascular-related conditions and diseases, including atherosclerosis, 
hypertension and diabetes (Vanhoutte 1997; Kojda and Harrison 1999; Ross 1999; 
Suwaidi, Hamasaki et al. 2000; Poredos 2001; Dandona 2002). In addition, enhanced 
ROS production was known to be detrimental to cardiovascular health (Kojda and 
Harrison 1999; Cai and Harrison 2000). COX-2 expression was augmented during 
aging (Wong, Leung et al. 2009) and in hypertensive state (Padilha, Pecanha et al. 
2008; Qu, Leung et al.), suggesting that up-regulation of COX-2 expression are 
associated with a decreased cardiovascular performance. The present study showed 
that SOPs attenuate endothelium-dependent vasorelaxation via increasing the ROS 
production and COX-2 expression, suggesting that SOPs may lead to the pathogenesis 
of a number of cardiovascular diseases. Since plant oils are important constituents of 
our diet, and that SOPs are generated when plant oils are subjected to frying and 
storage (Dutta and Appelqvist 1997; Grandgirard 2002; Hovenkamp, Demonty et al. 
2008), SOPs represent an important portion of our diet (van de Bovenkamp, 
Kosmeijer-Schuil et al. 1988; Lake and Scholes 1997). The present study showed that 
SOPs may be equally harmful as COPs (Wong, Ng et al. ； Nishio, Arimura et al. 1996; 
Lizard, Monier et al. 1999) to our cardiovascular health. Further investigations are 
needed to assess the suitability of SOPs consumption in our diet in long run. 
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2.5 Conclusion 
In summary, SOPs attenuated endothelium-dependent relaxation by increasing 
the production of ROS and COX-2 expression in the endothelial cells. The 
upregulated COX-2 expression was in turn caused by an increase in ROS production. 
This study generated novel information about the action of SOPs on the vasculature, 
and shall provide important insights concerning the consumption of P-sitosterol and 
SOPs in our diet. 
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Chapter Three p-Sitosterol Oxidation Products Possess Potential 
Voltage-operated Calcium Channel Blocking Effect in Vascular Smooth Muscle 
Cells 
3.1 Introduction 
3.1.1 Modes of Ca entry and efflux in vascular smooth muscle cells (VSMCs) 
2+ 
Modes of Ca entry and efflux in vascular smooth muscle cells (VSMCs) have 
been described in section 1.6.1 and section 1.6.2, respectively. 
3.1.2 Effect of cholesterol and COPs on VSMCs 
Some previous studies suggested that the plasma membrane of the VSMCs was 
very sensitive to cholesterol enrichment; increase in membrane cholesterol content 
was shown to increase the cytosolic calcium levels in VSMCs, associate with a 
decrease in membrane fluidity, and reveal a newly activated, 
dihydropyridine-sensitive calcium channel (Gleason, Medow et al. 1991). Evidences 
showed that Ca^^ influx through plasma membrane channels was an important signal 
in oxysterol-induced apoptosis (Ares, Porn-Ares et al. 1997). Ox-LDL could induce a 
more significant increase in [Ca ]i than native-LDL, which led to the higher 
atherogenic potential of Ox-LDL when comparing with native-LDL (Weisser, Locher 
et al. 1992). However, little is known about the effects of SOPs and p-sitosterol on the 
functionality and calcium homeostasis of the VSMCs. The previous chapter reported 
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the effects of SOPs and P-sitosterol on the endothelium-dependent relaxations of rat 
aorta. The main objective of this chapter was to examine the effects of SOPs and 
3-sitosterol on the functionality and calcium homeostasis of the endothelium-denuded 
aorta. The present study should allow a thorough understanding on the effect of SOPs 
and p-sitosterol on the functionality of vasculature. 
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3.2 Methodology and Materials 
3.2.1 Vessel preparation 
This study was approved by the Animal Ethics Committee, Chinese University 
of Hong Kong and conformed to Guide for the Care and Use of Laboratory Animals 
published by the United States National Institutes of Health (NIH Publication No. 
85-23, revised 1996). The process of the aortic ring preparation has been described in 
section 2.2.4. In particular, the endothelial layer of each aortic ring was mechanically 
disrupted by very gently rubbing the luminal surface of the artery with forceps tip to 
remove the endothelium. 
3.2.2 Isometric force measurement 
Isometric contractions were recorded with force transducer connected to a 
Maclab analogue-to-digital converter system. Thirty minutes after mounting in organ 
baths, all rings were firstly contracted by 60 mM K+ to test the contractile capacity of 
the arteries. After washing for twice, the vessels are contracted by 0.3 |LIM 
phenylephrine followed by addition of 3 ^iM acetylcholine (ACh) to test the removal 
of the endothelium (less than 10% relaxation). Removal of a functional endothelium 
was accepted i f no relaxation to 3 |LIM ACh was observed. The rings were 
subsequently rinsed in pre-warmed, oxygenated Krebs solution several times until 
stable baseline tone was restored. The rings were then allowed to equilibrate for 
additional 30 minutes and baseline tone was readjusted to 25mN when necessary. 
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Each experiment was carried out on rings prepared from different rats. 
The first set of experiments examined the relaxant effects of different 
concentrations of SOPs (10 jug/mL and 30 |Lig/mL) in 60 mM K+-contracted rings 
without endothelium. The relaxant responses were recorded for 3 hours until a 
steady-state contractile level was reached. The second set of experiments examined 
the effects of various inhibitors (Bay K 8644 10 nM, thapsigargin 3 \xM, ouabain 100 
|LIM, and nickel 300 JUM) on SOPs-induced relaxations in 60 mM K^-contracted 
endothelium-denuded aortas. These inhibitors were added 30 minutes before the 
Krebs solution was changed into 60 mM K+. In another set of experiments, the 
relaxant effects of SOPs (30 |Lig/mL) in U46619(l |LIM) or PDA(1 |iM; no external 
Ca)-contracted rings were examined in endothelium-denuded aortas. In the final set of 
experiments, the endothelium-denuded aortic rings were incubated with SOPs or 
ethanol (as solvent control) for 2 hours, followed by the concentration-dependent 
responses for Phe, U46619, and K+. 
3.2.3 Drugs 
Phenylephrine was purchased from RBI (Natick, MA USA). ACh, Bay K 8644, 
ouabain, and nifedipine were purchased from Sigma (St. Louis, MO, USA). 
Thapsigargin was purchased from Tocris (Bristol, UK). Nickel chloride was 
purchased from Merck (Germany). U46619 was purchased from Calbiochem. 
P-sitosterol was purchased from Meihe Company (Shenzhen, China). SOPs were 
made by our team as described in chapter 2. Bay K 8644, ouabain, nifedipine, 
6 0 
thapsigargin and U46619 were dissolved in dimethyl sulfoxide (DMSO) as stock 
solution, P-sitosterol and SOPs were dissolved in ethanol (100%) and all other drugs 
were dissolved in double-distilled water. Stock solutions were stored at -20 
Desired dilution was prepared in Krebs solution shortly before experimentation. 
DMSO or ethanol at 0.2% did not influence vessel tone. 
3.2.4 Data analysis 
Results are mean 士 SEM of n rings from different rats. Several rings prepared 
from the same artery were studied in parallel. Time-dependent relaxant effects of 
SOPs were investigated after various pharmacological interventions. The relaxation 
was expressed as percentage reduction in high K+-induced tone and the contractile 
force was presented as percentage of the mean value of 2-3 consecutive responses to 
60 mM K+. pECso is the negative logarithm of the drug concentration needed to cause 
50% of the maximal response (relaxation or contraction) (Emax) as determined by 
non-linear regression curve fitting (Graphpad Prism Software, version 5.0). Student's 
t-test (two-tailed) was used when 2 groups of means were compared. One-way 
ANOVA followed by the Bonferroni post-tests were used when more than 2 groups 
were compared. P-values less than 0.05 were regarded as statistically significant. 
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3.3 Results 
3.3.1 SOPs but not p-sitosterol induced relaxation in 60 mM K+ -preconstricted 
endothelium-denuded aorta 
In 60 mM K+-contracted endothelium-denuded aorta, the addition of SOPs 
induced relaxations in a concentration-dependent manner. SOPs (10 jig/mL) induced 
11.67 士 1.91% relaxation after 3 hours incubation (P<0.05 vs solvent control which 
caused 2.94 士 2.98o/o relaxation; Figure 3.2A). Furthermore, SOPs (30 |Lig/mL) 
induced 20.75 士 1.82 % relaxation after 3 hours incubation (尸<0.01 vs solvent control; 
尸 <0.01 vs 10 |Lig/niL SOPs; Figure 3.2A). In contrast, P-sitosterol did not induce 
relaxation in 60 mM K+-contracted endothelium-denuded aorta (Figure 3.2B). 
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Figure 3.2 Concentration-dependent relaxant responses to (A) SOPs or (B) 
P-sitosterol in 60mM KCl-contracted endothelium-denuded aortic rings. The 
percentage relaxation recorded 3 hours (A) after application of SOPs (10 |Lig/mL and 
30 |Lig/mL) or (B) after application of P-sitosterol (30 |xg/mL). Results are mean 士 
SEM of 3-5 experiments. Statistical difference is indicated by *户<0.05，**P<0.01 or 
***户<0.001 from controls. The line was connected when the points could not be 
sigmoidally fitted. 
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3.3.2 Both SOPs and p-sitosterol did not relax U46619-preconstricted 
endothelium-denuded aorta 
In contrast to the results when the aorta was contracted by 60 mM K+, SOPs 
did not induce relaxation in U46619-contracted endothelium-denuded aorta (Figure 
3.3A). Likewise, p-sitosterol did not induce relaxation in U46619-contracted 
endothelium-denuded aorta (Figure 3.3B). 
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Figure 3.3 Lack of the effect of (A) SOPs or (B) P-sitosterol to U46619-contracted 
endothelium-denuded aortic rings. The percentage relaxation recorded 3 hours (A) 
after application of SOPs (30 |ig/mL) or (B) after application of p-sitosterol (30 
|xg/mL). Results are mean 士 SEM of 3-6 experiments. The line was connected when 
the points could not be sigmoidally fitted. 
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3.3.3 Both SOPs and p-sitosterol did not relax PDA-preconstricted 
endothelium-denuded aorta 
Both SOPs and P-sitosterol did not cause relaxation when the 
endothelium-denuded aorta was contracted with PKC activator PDA in the absence of 
external calcium as compared to the solvent control groups (Figures 3.4A and 3.4B). 
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Figure 3.4 Lack of the effect of (A) SOPs or (B) P-sitosterol to PDA-contracted 
endothelium-denuded aortic rings in Ca^^ free KHS. The percentage relaxation 
recorded 3 hours (A) after application of SOPs (30 |xg/mL) or (B) after application of 
P-sitosterol (30 jig/mL). Results are mean 士 SEM of 3-4 experiments. 
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3.3.4 SOPs attenuated concentration-dependent responses to K+ 
To investigate the effect of SOPs on K+-induced contraction in 
endothelium-denuded aorta, concentration-dependent responses to K+ were studied. 
Pre-incubation with SOPs (30 |ig/mL) for 2 hours significantly inhibited the 
concentration-dependent responses to K+ (Emax二 93.17 士 4.27o/o for SOPs group; 
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Figure 3.5 Concentration-dependent responses to K+ after pre-incubation with SOPs 
(30 |ig/niL) for 2 hours in endothelium-denuded aortic rings. Results are mean 士 SEM 
of 7 experiments. Statistical difference is indicated by *P<0.05 from controls. 
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3.3.5 SOPs attenuated phenylephrine-induced contraction 
To investigate the effect of SOPs on phenylephrine-induced contraction in 
endothelium-denuded aorta, concentration-dependent responses to phenylephrine 
were studied. Contractions to phenylephrine were not altered when the 
endothelium-denuded aorta were treated with 30 |xg/mL SOPs for 30 and 60 minutes 
(Figures 3.6A& B). Contractions to phenylephrine were only slightly yet significantly 
inhibited after 120 minutes treatment with 30 jig/mL SOPs (Emax= 88.51 士 1.76% for 
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Figure 3.6 Concentration-dependent responses to phenylephrine after pre-incubation 
with SOPs (30 |Lig/mL) for (A) 30 minutes, (B) 60 minutes and (C) 120 minutes in 
endothelium-denuded aortic rings. Results are mean 士 SEM of 3-5 experiments. 
Statistical difference is indicated by **P<0.01 from controls. 
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3.3.6 Effect of SOPs on concentration-dependent responses to U46619 
Treatment with SOPs (30 |Lig/mL) for 120 minutes decreased the sensitivity of 
the endothelium-denuded aorta to contraction by U46619 (pECso： 8.42 士 0.10 in SOPs 
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Figure 3.7 Concentration-dependent responses to U46619 after pre-incubation with 
SOPs (30 lug/mL) for 120 minutes in endothelium-denuded aortic rings. Results are 
mean 士 SEM of 4-5 experiments. Statistical difference is indicated by *P<0.05 from 
controls. 
7 3 
3.3.8 Preincubation with thapsigargin did not affect SOPs -induced relaxation in 
60mM K+-preconstricted rings 
Preincubation with Bay K 8644, an L-type VOCC opener, abolished the 
vasodilating effect of SOPs in 60 mmol/L K+ -contracted endothelium-denuded aorta 
( E m a x ： -6.93 士 10.89O/O for Bay K 8644 plus SOPs treated group;�<0.05 vs SOPs 
treated group with Emax of 20.75 士 1.82o/o; Figure 3.9), suggesting that SOPs may 
induce vasorelaxation by blocking L-type VOCCs. 
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Figure 3.8 Effect o f Bay K 8644 on SOPs-induced relaxation in 60 m M 
K+-contracted aortic rings without endothelium. Results are mean 士 SEM of 5-8 
experiments. Statistical difference is indicated by P<0.05 from SOPs group. The line 
was connected when the points could not be sigmoidally fitted. 
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3.3.8 Preincubation with thapsigargin did not affect SOPs -induced relaxation in 
60mM K+-preconstricted rings 
Preincubation with thapsigargin, a SERCA inhibitor, did not affect 
SOPs-induced vasorelaxation (Emax: 17.61 士 3.44% for thapsigargin plus SOPs treated 
group;尸>0.05 vs SOPs treated group with Emax of 20.75 士 1.82o/o; Figure 3.10), 
suggesting that SOPs may not mediate the vasodilating effect through acting on 
SERCA or SOCCs. 
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Figure 3.9 Lack of the effect of thapsigargin on SOPs-induced relaxation in 60 mM 
K+-contracted aortic rings without endothelium. Results are mean 士 SEM of 5-7 
experiments. The line was connected when the points could not be sigmoidally fitted. 
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3.3.8 Preincubation with thapsigargin did not affect SOPs -induced relaxation in 
60mM K+-preconstricted rings 
Preincubation with ouabain, a Na+/K+ ATPase inhibitor, failed to affect 
SOPs-induced vasorelaxation (Emax: 18.68 士 4.65o/o for ouabain plus SOPs treated 
group; P>0.05 vs SOPs treated group with E a^x of 20.75 士 1.82o/o; Figure 3.11), 
suggesting that SOPs may not mediate the vasodilating effect through acting on 
Na^/K'^-ATPase. 
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Figure 3.10 Lack of the effect of ouabain on SOPs-induced relaxation in 60 mM K+ 
contracted aortic rings without endothelium. Results are mean 土 SEM of 5-10 
experiments. 
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3.3.10 Preincubation with nickel potentiated SOPs -induced relaxation in 60mM 
K^-preconstricted rings 
Interestingly, preincubation with nickel, an inhibitor of the NCX, potentiated 
SOPs-induced vasorelaxation (Emax=48.08 士 9.15o/o for nickel plus SOPs treated 
group; P<0.05 vs SOPs treated group with Emax of 20.75 士 1.82o/o; Figure 3.12). 
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Figure 3.11 Effect of Ni on SOPs-induced relaxation in 60 mM K contracted aortic 
rings without endothelium. Results are mean 士 SEM of 5 experiments. Statistical 
n 
difference is indicated by P<0.05 from SOPs group. 
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Table 3.1 
pECso and Emax (%) of various treatment on endothelium-independent vasorelaxation or 
contractioiL 
Treatment pECso Emax n 
Relaxations in 60 mM K+-preconstricted endothelium-denuded aorta 
Solvent control -2.68 ± 1.59 2.94 ±2.98 5 _ 
SOPs 10 iiig/mL -0.25 士 0.45 11.67± 1.91* 5 ^ 
SOPs 30 |ig/mL -0.46 士 0.22 20.75 士 1.82** 5 ^ 
Ethanol + Bay K 8644 10 nM ^ -3.45 ±2.87 8 _ 
SOPs 30 |ig/mL + Bay K 8644 10 nM 0.36 ±6.47 -6.93 ± 10.89# 8 _ 
Ethanol + Thapsigargin 3 i^M N.A. -3.64 士 6.75 7 
SOPs 30 lug/mL + Thapsigargin 3 \iM -1.01 士 0.32 17.61 ±3.44 7 _ 
Ethanol + Ouabain 100 |iM -1.65 ±0.60 2.75 ± 1.64 10 
SOPs 30 ^ig/mL + Ouabain 100 i^M -0.11 ±0.60 18.68 士 4.65 8 _ 
Ethanol + nickel300 .uM -1.19±0.72 8.38±3.71 5 ^ 
SOPs 30 ^ig/mL + nickel 300 |iM -0.48 ± 0.37 48.08 士 9.15# 5 _ 
Solvent control -1.68 ± 1.29 4.73 士 4.06 3 _ 
P-sitosterol 30 [xg/mL 0.42 士 4.68 4 _ 
Relaxations in U46619-preconstricted endothelium-denuded aorta 
Solvent control -1.23 士 1.66 3.90 ±4.20 6 _ _ 
SOPs 30 |Lig/mL ^ -6.86 ±7.18 6 _ _ 
Solvent control -0.77 ± 0.44 7.45 士 1.44 3 _ 
" ^ t o s t e r o l 30 ^ig/mL -2.00 ± 1.69 3.54 士 5.92 3 
Relaxations in PDA-preconstricted endothelium-denuded aorta 
Solvent control -0.80 ±0.43 27.05 士 7.24 4 _ 
SOPs 30 iiig/mL 0.10 ± 1.02 35.07 ±8.62 4 _ 
Solvent control 30.96 ± 9.24 3 _ 
P-sitosterol 30 \xg/mL N.A. 34.19 士 13.62 3 _ 
Concentration-dependent contraction for Phenylephrine 
Solvent control, 30 minutes 7.15±0.10 96.10 ±2.93 5 
SOPs 30 ^ig/mL, 30 minutes 7.00 ±0.04 93.14 士 1.88 5 
Solvent control, 60 minutes 7.33 士 0.09 96.42 ±3.88 3 
SOPs 30 |ig/mL, 60 minutes 7.38 ±0.16 89.94 ± 10.41 4 _ 
Solvent control, 120 minutes 7.40 ±0.11 97.78 士 1.09 4 
SOPs 30 lag/mL, 120 minutes 7.25 士 0.11 88.51 士 1.76** 4 _ 
Concentration-dependent contraction for U46619 
Solvent control, 120 minutes 8.85 ±0.12 107.05 ±0.57 4 
SOPs30 ^ig/mL, 120minutes 8.42±0.10* 110.33±2.11 — 5 ^ 
Concentration-dependent contraction for K+ 
Solvent control, 120 minutes 1.98±Q.ll 107.44 ±2.97 7 ~ 
SOPs 30 |ig/mL, 120 minutes 1.58±0.18 93.17 ±4.27* 7 
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Significant difference between control and treatment groups is indicated by *户<0.05, 
**尸<0.01, ***尸<0.001 vs solvent control; V<0.05, ##尸<0.01 vs SOPs 30 |ig/mL. 
Data are means 士 SEM of n experiments. N.A. indicates that the pECso is not 
available since the curve could not be sigmoidally fitted. 
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3.4 Discussion 
In this study, we examined the vascular effects of SOPs and p-sitosterol in the 
isolated rat aorta without endothelium. SOPs but not P-sitosterol remarkably relaxed 
high-K+-preconstricted endothelium-denuded aorta in a concentration-dependent 
manner. In contrast to the case when the aorta was contracted by high K+, SOPs could 
not relax endothelium-denuded aorta preconstricted with U46619; this suggests that 
SOPs induce vasorelaxation in VSMCs through a pathway that is activated by high K+ 
but not by U46619. Depolarization caused by raising extracellular K+ concentration is 
likely to activate VOCCs and also the reverse mode of NCX in VSMCs (Blaustein 
and Lederer 1999; Dong, Jiang et al. 2006) Therefore, it is likely that SOPs relaxed 
high-K+ contracted endothelium-denuded aorta by inhibiting VOCCs and/or by 
activating the forward mode of NCX. On the other hand, SOPs did not cause 
relaxation i f the endothelium-denuded aorta was contracted with PKC activator PDA 
in the absence of external calcium, suggesting that SOPs mediate the vasodilating 
effect through a calcium sensitive pathway. 
Blocking SERCA with thapsigargin did not affect SOPs-induced 
vasorelaxation in high-K+-preconstricted aorta, suggesting that SOPs may not mediate 
the vasodilating effect through SERCA or the SOCCs (which can be activated by 
store depletion). Similarly, blockade of Na+/K+-ATPase by ouabain did not affect 
SOPs-induced vasorelaxation, indicating that SOPs may not mediate the vasodilating 
effect through Na+/K+-ATPase. 
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In contrast, preincubation with Bay K 8644, which causes a marked 
prolongation of the open times of L-type VOCCs (Bean, Nowycky et al. 1984; 
Nowycky, Fox et al. 1985), abolished the vasodilating effect of SOPs, suggesting that 
SOPs induce vasorelaxation via blocking L-type VOCCs. In addition, nifedipine, the 
L-type VOCCs blocker, induced concentration-dependent relaxations in high 
K+-preconstricted endothelium-denuded aorta but only induced very minimal 
relaxations in U46619-preconstricted endothelium-denuded aorta (Figure 3.12). Since 
the relaxant effect of SOPs on respective constrictors (e.g. 60 mM KT and U46619) is 
similar to those of L-type VOCCs blocker nifedipine, this supports the notion that 
SOPs mediate the vasodilation effect through inhibiting L-type VOCCs. On the other 
hand, SOPs are likely to be a less potent inhibitor of L-type VOCCs than nifedipine 
since SOPs cannot cause a complete relaxation in high K+-preconstricted rings. 
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Figure 3.12 Concentration-dependent responses to nifedipine after being constricted 
by A) 60 mM K+(pEC5o=7.84 士 0.06; Emax=96.37 士 0.32%); B) U46619 (pEC5o=6.91 
± 0.24; Emax=11.50 士 1.940/0). Results are mean 士 SEM of 2 experiments. 
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SOPs reduced contractile responses to two receptor-dependent 
vasoconstrictors, phenylephrine and U46619, both weakly but significantly. As 
previously discussed, the L-type VOCC blocker nifedipine caused minimal relaxation 
in U46619-preconstricted rings, suggesting that U46619-induced contraction does not 
largely depend on the opening of L-type VOCCs in aorta. The findings that SOPs 
inhibited these agonist-induced contraction minimally are in line with the suggestion 
that SOPs inhibit L-type VOCCs. 
Previous studies suggested that excess membrane cholesterol alters the 
membrane fluidity (Bolotina, Omelyanenko et al. 1989) and increases calcium influx 
in the VSMCs (Bialecki and Tulenko 1989). Membrane cholesterol increases the 
L-type VOCC current in VSMCs, which was suggested to be more likely owing to the 
alteration in functional state of the channels rather than an increase in channel 
expression (Sen, Bialecki et al. 1992). In our present study, we showed that, unlike 
cholesterol, p-sitosterol did not increase the activity of L-type VOCCs. SOPs, on the 
other hand, even inhibit the activity of the L-type VOCCs in the VSMCs. 
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3.5 Conclusion and future work 
SOPs impaired the endothelium function and resulted in attenuated 
endothelium-dependent relaxations, as described in chapter 2. However, SOPs played 
a different role in VSMCs, where it relaxed the high K+-preconstricted 
endothelium-denuded aorta. The relaxant effect of SOPs was abolished by the VOCC 
opener Bay K 8644, while not affected by thapsigargin (SERCA inhibitor) and 
ouabain (Na+/K+-ATPase inhibitor). Furthermore, SOPs inhibited 
concentration-dependent contractions to phenylephrine, U46619 and K+. Interestingly, 
preincubation with nickel, a NCX inhibitor, potentiated the vasodilating effect of 
SOPs. It is not known whether the forward mode or the reverse mode of NCX was 
blocked by nickel since it is a non-specific NCX blocker. The enhancing effect of 
NCX blocker needs to be further confirmed by specific NCX blocker such as 
KB-R7943 to make further conclusions. In addition, further experiment should be 
conducted to investigate i f SOPs can directly inhibit Ca influx via L-type VOCCs by 
Ca measurement using confocal microscopy. 
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Chapter Four Involvement of Nitric Oxide in the Protective Effects of 
Phytosterols against Homocysteine-induced Impairment of 
Endothelium-dependent Relaxations of Rat Aorta 
4.1 Introduction 
Phytosterols, the membrane constituents of plants, are present at high 
concentrations in vegetable oils, nuts, seeds and grains. Phytosterols are structurally 
similar and functionally analogous to cholesterol (Hovenkamp, Demonty et al. 2008; 
Clifton 2009). p-Sitosterol, stigmasterol, and brassicasterol are the common members 
of phytosterols. They share the four-ring structure common to cholesterol and differ 
from cholesterol that they have modified side chains at C-24. Phytosterols are most 
famous for their significant effect in decreasing the circulating cholesterol levels, 
which are believed to be one of the major causes for the initiation and progression of 
the atherosclerotic process (Pentikainen, Oomi et al. 2000; Wang, Greilberger et al. 
2001). Numerous evidences show that food supplemented with phytosterols has 
significant cholesterol-lowering effects (Jones, Howell et al. 1998; Weststrate and 
Meijer 1998; Hendriks, Weststrate et al. 1999; Cicero, Fiorito et al. 2002). In addition, 
phytosterols also possess anti-inflammatory effects (Mahajan and Mehta ； Valerio and 
Awad), anti-proliferative effects (Chien, Lee et al. ； Mahajan and Mehta), and immune 
function-modulating effects (Alappat, Valerio et al.). Taken together, phytosterols 
possess various beneficial biological activities apart from the well-known 
cholesterol-lowering effect. 
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Diets are the only source of phytosterols in human beings since phytosterols 
cannot be endogenously synthesized in our bodies (Schoenheimer 1931; Ling and 
Jones 1995). Absorption of P-sitosterol was 5% (or less) of our daily intake, which 
was considerably lower than that of cholesterol which ranges from 45% to 54% of our 
intake (Salen, Ahrens et al. 1970; Salen, Shore et al. 1989). The increased daily intake 
of phytosterols can lead to an increase of circulating phytosterols. Several studies 
have shown that populations consuming a predominantly plant-based diet have a 
lower incidence of cardiovascular disease (CVD) as comparing with meat-based diets 
(Awad, Smith et al. 2001). 
Endothelial dysfunction has been considered as one of the initiating events of 
atherosclerosis and is associated with a decrease in either production or bioactivity of 
the endothelium-derived relaxing factor nitric oxide (NO). Recent evidences indicate 
that endothelial dysfunction, occurring early in the process of atherogenesis, 
contribute to the formation, progression, and complications of atherosclerotic plaque 
(Sitia, Tomasoni et al. 2010). Increased endothelial dysfunction and inflammation lead 
to the derangement of the permeability, elasticity and thickness of vascular wall 
before atherosclerotic lesions arise (Westerweel, Luyten et al. 2007).A number of 
studies showed that patients with cardiovascular disease risk factors while not yet 
showing clinical signs of atherosclerosis were affected by endothelial dysfunction, as 
indicated by the impaired relaxations in response to endothelial vasodilators such as 
acetylcholine and bradykinin (Zardi and Afeltra 2010). 
Homocysteine (HC) is a sulfur-containing amino acid that is metabolized 
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from methionine, an essential amino acid derived from dietary protein. Plasma total 
HC concentrations range from 5 to 15 j iM in normal individuals while individuals 
with plasma HC levels above 15 juM are considered to have hyperhomocysteinemia 
(Ueland, Refsum et al. 1993). HC accumulation in plasma being responsible for its 
atherogenic effects was firstly demonstrated in children with the inborn defect of HC 
metabolism by McCully (McCully 1969). Later on, many epidemiological studies 
confirm that elevated HC levels are associated with an increased risk of 
atherosclerosis (Boushey, Beresford et al. 1995; Graham, Daly et al. 1997; Moustapha 
and Robinson 1998; Cahill, Karabatzaki et al. 2000). HC is therefore considered as an 
independent risk factor for atherosclerosis and other vascular lesions. 
Growing evidence suggests that endothelial dysfunction plays a major role in 
the vascular injury observed in hyperhomocysteinemia although the mechanisms are 
not fully elucidated (Bellamy and McDowell 1997; Woo, Chook et al. 1997). Indeed, 
endothelial injury caused by HC has been observed in either animal models (Harker, 
Ross et al. 1976) or cell culture studies (Wall, Harlan et al. 1980; Blundell, Jones et al. 
1996). It has been reported that reactive oxygen species (ROS) such as superoxide 
anion (O2') and hydrogen peroxide (H 2O2 ) are formed during auto-oxidation of the 
readily oxidized HC (Starkebaum and Harlan 1986; Wems, Walton et al. 1989). The 
impairment effects of HC on endothelial function have been ascribed to the reduced 
bioavailability of NO due to auto-oxidation of HC in plasma, which leads to the 
oxidative inactivation of NO (Welch and Loscalzo 1998). Many recent studies 
indicate that HC inhibits endothelium-dependent relaxation via a mechanism that is 
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related to intracellular generation of oxygen-derived free radicals (Lang, Kredan et al. 
2000; Shukla, Thompson et al. 2002; Fu, Xiong et al. 2003). Therefore, HC has been 
used in numerous studies as a reagent to generate ROS to induce endothelium 
dysfunction (Li, Yi et al. 2002; Shukla, Thompson et al. 2002). 
Though many biological activities of phytosterols have been investigated, it is 
not known whether the phytosterols have protective potential to the endothelium 
against oxidative stress-induced impairment. In the present study, the effects of 
phytosterols on the HC-induced impairment of endothelium-dependent relaxations 
were investigated. This study may provide some profound information on how 
phytosterols protect the vascular system. 
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4.2 Materials and method 
4.2.1 Vessel preparation 
This study was approved by the Animal Ethics Committee, Chinese University 
of Hong Kong and conformed to Guide for the Care and Use of Laboratory Animals 
published by the United States National Institutes of Health (NIH Publication No. 
85-23, revised 1996). The process of the aortic ring preparation has been described in 
section 2.2.4. 
4.2.2 Isometric force measurement 
Isometric tensions were recorded with force transducer connected to a Maclab 
analogue-to-digital converter system. Thirty minutes after mounting in organ baths, 
all rings were first contracted by 60 mM K+ to test their contractile capacity. After 
washing for twice, the vessels were contracted by 0.3 | iM phenylephrine followed by 
addition of 3 | iM acetylcholine (ACh) to test the integrity of the endothelium (over 
80% relaxation). Al l rings were subsequently rinsed in pre-warmed, oxygenated Krebs 
solution several times until stable baseline tone was restored. The rings were then 
allowed to equilibrate for additional 30 minutes and baseline tone was readjusted to 
25mN when necessary. Each experiment was carried out on rings prepared from 
different rats. To impair endothelium-dependent relaxation, the rings were exposed for 
45 minutes to HC (300 |iM) before performing the concentration-dependent responses 
to ACh. To investigate whether the phytosterol treatment could improve endothelial 
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function in rings challenged by HC, rings were exposed for 30 minutes to 
brassicasterol/p-sitosterol/stigmasterol/SOPs/solvent, followed by 45-minute 
incubation with HC before the obtaining concentration-dependent responses to ACh. 
As positive control, the effect of tiron (a ROS scavenger) was also tested on the 
impaired relaxations to ACh in HC-treated aortas. 
4.2.3 Western blotting 
Isolated aortas were incubated with HC (300 jiM) or the same volume of 
vehicle. Some rings were co-treated with brassicasterol (30 |ig/mL) and homcysteine 
(300 luM). After treatment, the rings were then frozen in liquid nitrogen and stored at 
-80 ^ C for later processing. The treated arteries were subsequently homogenized with 
ice-cold RIPA lysis buffer containing PBS with 1% NP-40, 0.5% sodium 
deoxycholate, 1% SDS, 1% protease inhibitor cocktail [Leupeptin (1 |ig/niL), 
Aprotinin (5 ^ig/mL), PMSF (100 ^ig/mL), sodium orthovanadate (100 |ig/mL), EGTA 
(200 |ig/mL) and EDTA (200 |ig/mL) and phosphatase inhibitor cocktail [NaF (250 
mM), p-glycerolphosphate (500 ^g/mL) and HEPES (50 mM, pH7.3)]. The arteries 
lysates was then centrifuged at 16,000g, 4°C for 20 minutes. The supernatant was 
collected and protein concentration was determined by Bradford Assay (Bio-Rad 
Laboratories). One volume of 2x gel loading buffer containing 10% 
P-mercaptoethanol was added and the samples were denatured by boiling for 10 
minutes. For each sample, equal amount of total protein was separated under reducing 
conditions on either 7.5% or 12.5% SDS-polyacrylamide gel. Pre-stained Novex 
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Sharp Standard marker (Invitrogen) was loaded in parallel as a standard molecular 
weight marker. The resolved proteins were electroblotted to immobilon-P 
polyvinylidene difluoride (PVDF) membrane (Millipore) using wet transfer at l lOV 
for 80 minutes at The membranes were blocked with 5% non-fat milk for 1 hour 
at room temperature. Blots were incubated with primary antibody overnight at 4°C in 
5% non-fat milk. Primary antibodies and dilutions used were: rabbit polyclonal to 
eNOS at 1:300 (Abeam), mouse monoclonal to cyclooxygenase (COX)-l at 1:500 
(Cayman), rabbit polyclonal to COX-2 at 1:300 (Cayman), mouse monoclonal to 
SOD-1 at 1:2000 (Santa cruz), mouse monoclonal to SOD-2 at 1:2000 (Santa cmz), 
mouse monoclonal to glyceraldehyde-3 -phosphate dehydrogenase (GAPDH) at 
1:10000 (Ambion). GAPDH was used as a housekeeping protein. After washing with 
TEST, blots were incubated with horseradish peroxidase-conjugated secondary 
antibodies (rabbit anti-mouse and goat anti-rabbit antibodies; both from Dako) at a 
dilution of 1:5000 in 5% non-fat milk for 1 hour at room temperature. The membranes 
were developed with an enhanced chemiluminescence detection system (Western 
lighting plus-ECL; PerkinElmer, USA) and then exposed to X-ray films (Fuji). The 
signal intensities were quantified using AlphaEase software of the FluorChemTM 
8000 digital gel documentation system (Alpha Innotech Corp.). For each experimental 
group, signal intensity of the target protein wil l first be normalized to that of the 
housekeeping protein GAPDH. The value obtained from treatment group will then be 
normalized to that of the control group. 
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4.2.4 1，l-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging capacity 
The scavenging activities of the three phytosterols were determined according 
to Chu's method (Chu, Chang et al. 2000) with a few modifications (Leung, Yao et al. 
2006). An aliquot of 1 mL of 0.2 mM DPPH radicals in methanol was added into a 15 
mL falcon tube containing 1 mL of phytosterols at different concentrations (1, 3, 10, 
30 |ig/mL, respectively). Ethanol was added as a solvent control. DPPH is a stable 
free radical with a deep purple color in ethanolic solution and has a typical absorbance 
at 517 nm, but becomes pale yellow when it is trapped by an antioxidant. The reaction 
mixture was mixed thoroughly and kept in dark for 30 minutes. The absorbance (A) 
was then determined by measuring at 517 nm with UV-vis spectrophotometer 
(Spectronic⑧ GENESYSTM 5, USA). Vitamin E was employed as positive control. 
Al l the tests were run in triplicates. The inhibition percentage on DPPH radicals was 
calculated by the following equation: 
inhibition percentage Di^Pi/ra金=�洲加?(為i?) - (為口）父川。。/。 
Control (A^^j) 
Control (A517) represents the absorbance of vehicle control at 517 nm while 
Sample (A517 ) represents the absorbance of respective sample at 517 nm with UV-vis 
spectrophotometer. 
4.2.5 Primary culture of rat aortic endothelial cells 
The process of isolation and primary culture of rat aortic endothelial cells has 
been described in section 2.2.7. 
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4.2.6 Measurement intracellular oxidative stress 
Intracellular level of ROS in primary rat aortic endothelial cells were 
determined by dihydroethidium (DHE) (Molecular Probes) fluorescence emitted upon 
oxidation. Endothelial cells were seeded on coverslips to -60-70% confluence and 
incubated with HC (300 juM) for 5, 15, 30, 45 or 60 minutes for determination of the 
peak ROS level stimulated by HC. In one set of experiments, cells were pre-incubated 
with an ROS scavenger, tiron (1 mM) or catalase (1000 U/mL), for 30 minutes before 
45 minute-incubation with HC. In another set of experiments, cells were 
pre-incubated with the phytosterols at the concentration employed in functional study 
for 75 minutes. Cells were rinsed with normal physiological saline solution (NPSS in 
mM, 140 NaCl, 5 KCl, 1 CaCb, 1 MgCl], 10 glucose, 5 HEPES, pH 7.4) after the 
treatments and incubated in 5 j iM DHE for 20 minutes at 37 in dark. After a rinse 
in NPSS, fluorescence was observed under a confocal microscope (Olympus 
Fluoview) with 515-nm excitation and filtered through a 585-nm long pass filter. 
DHE fluorescence intensity was analyzed by Fluoview (version 1.5; FV10-ASW1.5) 
and the data were expressed in fold change compared with control treated with 
vehicle (final concentration of 0.3% ethanol). 
4.2.7 Nitric oxide (NO) measurement 
Intracellular level of NO in primary rat aortic endothelial cells was determined 
by DAF-FM diacetate (Molecular Probes, Eugene, OR, USA) fluorescence emitted 
upon addition of ACh. Endothelial cells were seeded on coverslips to ~60-70% 
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confluence and incubated with drugs for determination of the NO release upon 
addition of 10 joM ACh. In one set of experiments, cells were pre-incubated with 
vehicle for 75 minutes before loading dye. In another set of experiments, cells were 
pre-incubated with brassicasterol (30 \ig/mL) or vehicle for 30 minute followed by the 
addition of HC (300 |iM) for another 45 minutes. Cells were rinsed with NPSS after 
the treatments and incubated in 2 |iiM DAF-FM diacetate for 20 minutes at 37 in 
dark. After a rinse in NPSS, NO fluorescence was measured by a confocal scanning 
unit (FVIOOO, Olympus, Tokyo, Japan) with 488 nm excitation and an emission filter 
of 505-525 nm. Data were taken every 15 seconds for 20 minutes. Changes in [NO]i 
were displayed as a ratio of fluorescence relative to the initial intensity (Fl/FO), and 
analyzed by the Fluoview software (Olympus; version 1.5; FV10-ASW1.5). 
4.2.8 Drugs 
Acetylcholine (ACh), catalase, HC, 1, l-diphenyl-2-picrylhydrazyl (DPPH), 
3•amino-1, 2, 4-triazole (ATZ) and stigmasterol were purchased from Sigma (St. 
Louis, MO, USA). Phenylephrine (Phe) were purchased from RBI (Natick, MA, 
USA). Tiron was purchased from Riedel-de Haen (Hanover, Germany). P-sitosterol 
was purchased from Meihe Company (Shenzhen, China). SOPs were made by our 
team as described in chapter two. DAF-FM and DHE were purchased from Invitrogen 
(Carlsbad, CA, USA). DAF-FM and DHE were dissolved in dimethyl sulfoxide 
(DMSO) as stock solution; p-sitosterol, brassicasterol, stigmasterol and SOPs were 
dissolved in ethanol (100%); DPPH was dissolved in methanol and all other drugs 
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were dissolved in double-distilled water. Stock solutions were stored at -20 
Desired dilution was prepared in Krebs solution shortly before experimentation. 
DMSO or ethanol at 0.2% did not influence vessel tone. 
4.2.9 Data Analysis 
Data are mean 士 SEM of n rings from different rats. pECso is the negative 
logarithm of the drug concentration needed to cause 50% of the maximal response 
(relaxation or contraction) (Emax) as determined by non-linear regression curve fitting 
(Graphpad Prism Software, version 5.0). Student's t-test (two-tailed) was used when 2 
groups of means were compared. One-way ANOVA followed by the Bonferroni post 




4.3.1 Impairment of endothelium-dependent relaxation by HC was reversed by 
ROS scavenger 
HC was found to attenuate ACh-induced relaxation in terms of Emax but not 
pECso (Figure 4.1, Table 4.1). Incubation with 1 mM tiron, a ROS scavenger, 
protected the endothelial function in HC-treated aortas and completely restored the 
ACh-induced relaxation (Figure 4.1, Table 4.1). This indicated the involvement of 
ROS in the HC-induced impairment of endothelium-dependent relaxations. 
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A) Raw traces showing ACh-mediated relaxations in endothelium-intact aortic rings 
without HC (upper) or with HC (300 |uM) (middle) or in the presence of both 
tiron (1 mM) and HC (300 _ (bottom). 
B) ACh-induced relaxations when the rat aortas were incubated with HC (300 ^M) 
or HC with tiron (ImM) for 45 minutes (n=5-14). HC attenuated ACh-induced 
endothelium-dependent relaxations in term of Emax. Tiron restored ACh-mediated 
relaxations in HC-treated aortas. ** 户<0.01 vs (EtOH + HC) group. 
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4.3.2 Brassicasterol reversed HC-induced endothelial dysfunction in a 
dose-dependent manner 
The representative records in Figure 4.2A show that exposure to HC resulted 
in markedly reduced relaxations to ACh in rings with endothelium. The reduced 
relaxations were significantly prevented by 30-minute pre-treatment with 
brassicasterol (Figure 4.2, Table 4.1). Brassicasterol were found to improve the 
HC-impaired relaxations in a dose-dependent manner (Figure 4.2, Table 4.1). 
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Figure 4.2 
A) Raw traces showing ACh-mediated relaxations in endothelium-intact aortic rings 
in the presence of HC without (upper) or with treatment with 10 jug/mL (middle) 
and 30 fig/rtiL (bottom) brassicasterol. 
B) Effect of brassicasterol (10 |ig/mL and 30 ^ig/mL) on ACh-mediated relaxations 
in HC-treated aortas (n=7-14). Brassicasterol restored HC-induced impairment of 
endothelium-dependent relaxations in a concentration-dependent manner. *P<0.05, 
** P<0.01 vs (Ethanol + HC) group. 








4.3.3 P-Sitosterol and stigmasterol reversed HC-induced endothelial dysfunction 
Similar to brassicasterol, 3 |Lig/mL P-sitosterol was found to reverse the effect 
of HC (Figure 4.3A, Table 4.1). However, further increasing the dose of p-sitosterol 
used to 10 |Lig/mL did not induced further reversal effect (Figure 4.3A, Table 4.1), 
suggesting that 3 jiig/mL was the maximum dose. Treatment of stigmasterol also 
restored the HC-induced impairment of relaxations (Figure 4.3B, Table 4.1). 
Stigmasterol at 3 |Lig/mL significantly reversed the HC-induced attenuation of 
ACh-induced relaxations. However, stigmasterol at 10 |ig/mL failed to rescue the 
HC-induced impairment, probably due to the larger experimental variations in the 
stigmasterol 10 |Lig/mL group. 
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Figure 4.3 
A) Effect of p-sitosterol (3 ^ig/mL and 10 |Lig/mL) on ACh-mediated relaxations 
in HC-treated aortas (n=8-14). p-Sitosterol restored HC-induced impairment 
of endothelium-dependent relaxations. 
B) Effect of stigmasterol (3 |ug/mL and 10 |^g/mL) on ACh-mediated relaxations 
in HC-treated aortas (n=6-14). Stigmasterol at 3 |^g/mL restored HC-induced 
impairment of endothelium-dependent relaxations. *尸<0.05, ** P<0.01 vs 
(Ethanol + HC) group. 
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4.3.4 Effects of P-sitosterol oxidation products (SOPs) on HC-induced endothelial 
I 
I dysfunction 
In contrast to p-sitosterol, SOPs at 30 jug/mL failed to restore the HC-induced 
impairment of endothelium-dependent relaxations (Figure 4.4, Table 4.1). This 
indicated that p-sitosterol loses the protective effect against oxidative stress after it is 
oxidized. 
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Figure 4.4 Effect of SOPs (30 |Lig/mL) on ACh-mediated relaxations in HC-treated 
aortas (n二 11-14). SOPs failed to reverse the impairment caused by HC.###尸<0.001 vs 
solvent control group. 
I, i 
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4.3.5 Effects of brassicasterol and P-sitosterol on HzCh-induced impairment of 
endothelium-dependent relaxation 
Exposure of aortas to 150 |LIM H2O2 for 30 minutes impaired ACh-induced 
relaxations. Treatment with 30 jug/mL brassicasterol (30 minutes before the addition 
of H2O2) had a trend to reverse the effect of H2O2 (Figure 4.5A, Table 4.1). On the 
other hand, treatment with P-sitosterol (10 ^ig/mL) for 30 minutes before exposing to 
150 i^M H2O2 significantly reversed the impaired relaxation caused by H2O2 (Figure 
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Figure 4.5 
A) Effect of brassicasterol (30 jug/mL) on ACh-mediated relaxations in 
H202-treated aortas (n=5). Brassicasterol (30 |ig/mL) had a trend to restore 
H202-induced impairment of endothelium-dependent relaxations [尸=0.06 for 
brassicasterol (30 |ig/mL) plus H2O2 group vs HsC^-treated group]. 
B) Effect of P-sitosterol (10 fig/mL) on ACh-mediated relaxations in 
H202-treated aortas (n=6). p-sitosterol (10 |Lig/mL) significantly restored 
H202-induced impairment of endothelium-dependent relaxations. *P<0.05 vs 
(Ethanol + H2O2) group 
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4.3.6 Phytosterols did not directly scavenge free radicals 
To determine i f phytosterols rescue the impairment of endothelium-dependent 
relaxation by directly scavenging free radicals, in vitro DPPH assay was performed. 
The concentrations of phytosterols that were shown to protect endothelium function 
did not exert a free radical-scavenging effect (Figure 4.6). On the other hand, Vitamin 
E as positive control produced concentration-dependent increases in the free 
radical-scavenging activity (Figure 4.6D). Vitamin E at 3, 10, and 30 |Lig/mL caused 
21.60 士 2.06, 40.81 士 1.06 and 90.47 士 0.14o/o of free-radical scavenging activities 
(P<0.05, P<0.001 and 户<0.001 vs Vitamin E at 1 |Lig/mL). The results suggested that 
phytosterols may not exert their effect on restoring HC-induced endothelial 
dysfunction by free radical-scavenging activity. 
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Figure 4.6 Lack of free radical-scavenging activity of brassicasterol (A), P-sitosterol 
(B), and stigmasterol (C) at the tested concentrations. Vitamin E was used as a 
positive control for the free radical-scavenging effect (D). Results are mean 士 SEM of 
3 experiments. Significant difference in comparison with a concentration of 1 |Lig/mL 
is indicated by *尸<0.05; ***尸<0.001. 
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4.3.7 HC and brassicasterol did not affect the expression of SOD-1, SOD-2, 
eNOS, COX l , and COX-2 in aorta 
I To determine i f HC and brassicasterol affect endothelium-dependent 
i 
relaxation by altering the expressions of the key enzymes involved in controlling 
cellular ROS levels, western blot was performed to determine the expressions of 
SOD-1 and SOD-2 upon different treatments. In endothelium-intact aorta, HC 
treatment did not alter the expressions of either SOD-1 or SOD-2 (SOD-1: 0.96 ±0.16 
vs 1.00 ± 0.11 in control group,尸>0.05; SOD-2: 0.98 士 0.05 vs 1.00 士 0.09 in control 
group,尸>0.05) (Figures 4.7A - B). Likewise, treatment with brassicasterol plus HC 
did not further change the expressions of SOD-1 and SOD-2 (SOD-1: 0.99 士 0.04 vs 
1.00 士 0.11 in control group, P>0.05; SOD-2: 1.01 士 0.04 vs 1.00 士 0.09 in control 
group,尸>0.05) (Figures 4.7A - B). 
Similarly, to investigate i f HC and brassicasterol affect endothelium-dependent 
relaxation by altering the expressions of key enzymes involved in regulating the levels 
of vasodilating and vasoconstricting factors in rat aortic endothelium, expression of 
eNOS, COX-1 and COX-2 upon different treatments were also determined. In 
endothelium-intact aorta, HC treatment did not alter the expression of eNOS, COX-1 
and COX-2 (eNOS: 0.80 士 0.13 vs 1.00 士 0.17 in control group,户>0.05; COX-1:0.83 
士 0.15 vs 1.00 士 0.16 in control group,尸>0.05; COX-2: 0.69 士 0.15 vs 1.00 士 0.18 in 
control group, P>0.05) (Figures 4.7C - E). Furthermore, co-treatment with 
brassicasterol and HC did not further change the expressions of these enzymes (eNOS: 
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0.79 士 0.26 vs 1.00 ± 0.17 in control group, P>0.05; COX-1: 1.00 ± 0.16 vs 1.00 士 
0.16 in control group,尸>0.05; COX-2: 0.80 士 0.16 vs 1.00 士 0.18 in control group, 
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Figure 4.7 (Upper panels of A - E) Representative blots showing the effects of HC 
/brassicasterol+HC treatment on the expression of SOD-1 (A), SOD-2 (B), eNOS (C), 
COX-1 (D) and COX-2 (E) in endothelium-intact aortas; (Lower panels of A - E) 
Western blot analysis showing the expression of SOD-1 (A), SOD-2 (B), eNOS (C), 
COX-1 (D) and COX-2 (E) after HC /brassicasterol+HC treatment. Both treatments 
did not alter the expressions of all the enzymes investigated. GAPDH was used as the 
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4.3.8 HC increased ROS production in primary rat aortic endothelial cells 
HC (300 |iM) induced a time-dependent elevation in intracellular oxidative 
stress as reflected by a significant increase in DHE fluorescence in cells treated with 
HC for 5, 15, 30, 45 and 60 minutes, respectively (Figure 4.8A). This HC-stimulated 
ROS level peaked at 45 minutes (Figure 4.8B), which could be reversed by catalase 
(P<0.05) and marginally by tiron (P=0.06) (Figure 4.8C). The results indicated that 
HC elevated the intracellular oxidative stress level in rat aortic endothelial cells 
I 
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Figure 4.8 
A) Representative photos showing the time dependent effects of HC (300 |iM) on the 
intracellular oxidative stress level in rat aortic endothelial cells as detected by 
DHE. 
B) Bar graph summarizing the time-dependent effects of HC (300 |LIM) on the 
intracellular oxidative stress level in rat aortic endothelial cells. HC increased the 
intracellular oxidative stress level in a time-dependent way by a significant 
increase in DHE fluorescence with the ROS level peaked at 45 minutes. *** 
P<0.001 vs control. Values are mean 士 SEM of 4 experiments. 
C) Bar graph summarizing the effects of co-treatment of HC (300 |IM) with tiron (1 
mM), with catalase (1000 U/mL), and with ATZ (50 mM) on the intracellular 
oxidative stress level in rat aortic endothelial cells. Treatment with HC (300 [iM) 
for 45 minutes increased ROS level, which could be reversed by catalase. The 
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ROS scavenger tiron also tended to reverse the effect of HC (P=0.06). On the 
other hand, the catalase inhibitor ATZ plus HC treatment did not further alter 
DHE fluorescence. *P<0.05, **尸<0.01 vs control. Values are mean 士 SEM of 2-8 
experiments. 
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4.3.9 Brassicasterol did not reverse the ROS production by HC treatment in the 
endothelial cells 
Pre-treatment of the rat aortic endothelial cells with brassicasterol (30 |u.g/mL) 
did not reverse the ROS production caused by HC (Figure 4.9A). Surprisingly, 
endothelial cells treated with brassicasterol (30 jig/mL) alone for 75 minutes caused a 
significant increase in DHE fluorescence which could be reversed by catalase (Figure 
4.9A). On the other hand, the catalase inhibitor ATZ could completely reverse the 
effect of HC on the endothelium-dependent relaxations. Interestingly, brassicasterol 
alone did not affect the ACh-induced relaxation (Figure 4.9C) regardless of its effect 
on elevating the intracellular oxidative stress (c./ Figure 4.9A). Taken together, the 
results suggested brassicasterol did not restore the endothelium function by reversing 
the ROS production by HC. 
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Figure 4.9 
A) For rat aortic endothelial cells treated with brassicasterol (30 |ig/mL) for 75 
minutes, there was a significant increase in DHE fluorescence which could be 
reversed by catalase. The results suggested that brassicasterol (30 |ig/mL) 
elevated the intracellular oxidative stress level in rat aortic endothelial cells. * * * 
尸<0.001 vs control. Values are mean 士 SEM of 2-22 experiments. 
B) Effect of the catalase inhibitor ATZ on ACh-mediated relaxations in HC-treated 
aortas (n=2). ATZ completely reversed the effect of HC on the 
endothelium-dependent relaxations of rat aortas. * 尸<0.05 vs (EtOH + HC) 
group. 
C) Effect of brassicasterol (30 jiig/mL) on ACh-mediated relaxations in normal rat 
aortas (n=3). Brassicasterol (30 |ig/mL, 75 minutes) did not affect the 
endothelium-dependent relaxations. 
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4.3.10 Effect of L-NAME on reversing the effect of brassicasterol on 
ACh-induced relaxation 
The effect of brassicasterol on ACh-induced relaxation was completely 
abolished by pre-treatment with 100 |iM L-NAME (Figure 4.10, Table 4.1). This 
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Figure 4.10 Effect of L-NAME on the reversal effect of brassicasterol on HC-induced 
impairment on ACh-induced relaxation. L-NAME (100 |LIM) completely abolished the 
effect of brassicasterol (30 |Lig/mL) on ACh-mediated relaxations in HC-treated aortas. 
•PO.OOl vs [Br (30 [ig/mL) + HC] group. 
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4.3.11 Brassicasterol reversed the inhibitory effect of HC on ACh-induced NO 
production in endothelial cells 
Preliminary data showed that HC (300 |iM) decreased the NO production 
upon 10 \iM ACh as reflected by an inhibited increase of DAF-FM diacetate 
fluorescence in rat aortic endothelial cells (1.08 士 0.01 vs 1.15 士 0.02 in solvent 
control group, P<0.05, n=3-4 from 4 independent cell isolations) (Figure 4.11). 
Pretreating the endothelial cells with brassicasterol has a trend to restore the effect of 
HC (1.16 士 0。03 Vs 1.08 士 0.01 in HC treated group,尸=0.069, n=3-4 from 4 
independent cell isolations). The results suggested that HC decreased the intracellular 
NO release in rat aortic endothelial cells while brassicasterol restored the NO 
production by reversing the effect of HC. 
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Figure 4.11 Effects of brassicasterol (30 jug/mL) on the ACh-induced intracellular 
NO production in HC treated rat aortic endothelial cells. HC (300 |iM) decreased the 
NO production upon 10 |LIM ACh comparing with control group; Pretreating the 
endothelial cells with brassicasterol has a trend to restore the NO production by 
reversing the effect of HC (P=0.069).*P<0.05 vs control. Values are mean 士 SEM of 
3-4 experiments. 
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Table 4.1 
pECso and Emax (%) of various treatment on endothelium-dependent vasorelaxation. 
Treatment pECso Emax n 
ACh-induced relaxation after pretreatment with phytosterols in Homocysteine(HC)-treated aortas 
Solvent control 6.69 ±0.09 91.74 ± 1.95 7 _ 
Ethanol + HC 6.31 ±0.13 31.61 ±3.94— 14 
Tiron 1 mM + HC 6.81 ±0.14* 82.78 ±8.27** 5 _ 
Br 10 ^ig/mL + HC 6.37 ±0.13 46.78 士 5.03* 7 _ _ 
Br 30 |ig/mL + HC 6.46 ±0.13 66.27 ±7.95** 9 _ 
P-sito 3 |ig/mL + HC 6.46 ±0.11 59.61 ±6.35** 7 _ _ 
P-sito 10 ^ig/mL + HC 6.40 ±0.19 59.84 士 10.56* 8 _ _ 
stig 3 \xg/mL + HC 6.3Q±Q.13 67.19 ±9.24** 7 _ _ 
stig lO^ig/mL + HC 6.68 ±0.30 44.49 ± 12.86 6 _ 
SOPs 30 ^ig/mL + HC 6.13 ±0.19 39.54 ± 11 
ATZ 50 mM + HC 6.34 ±0.28 90.96 ±6.34* 2 ^ 
L-NAME 100 |iM + Br 30 ^ig/mL + HC 6.11 ±0.64 3.89± 4 ^ 
Br 30 [ig/mL 6.70 ±0.10 83.08 士 8.20 3 ~ 
ACh-induced relaxation after pretreatment with phytosterols in HiOi-treated aortas 
Solvent control 6.84 ±0.07 89.52 ± 6.66 3 _ 
Ethanol + H2O2 6.39 ±0.38 33.70 ±7.69^^ 6 _ 
p-sito 10 |ig/mL + H2O2 6.63 ±0.18 55.59 ±8.24* 6 _ 
Br 30 ^g/mL + H2O2 6.68 ± 0.25 61.70 ± 13.74 5 _ 
Significant difference between control and treatment groups is indicated by *尸<0.05, 
**尸<0.01, ***P<0.001 vs (Ethanol + HC)/ (Ethanol + H2O2) group; #尸<0.05, 
储POM, ###户<0.001 vs vehicle control group. Data are means 士 SEM of n 
experiments. 
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4.4 Discussion 
The oxidative stress hypothesis is frequently employed to explain the 
damaging effects on vascular cells and tissues caused by HC and other thiols which 
possess pro-oxidant activity (Loscalzo 1996). Many in vitro studies show that 
preincubation of rat or rabbit aortic rings with HC impaired the 
endothelium-dependent relaxations. This inhibitory effect was significantly reversed 
by the presence of antioxidants such as tiron or both SOD and catalase (Emsley, 
Jeremy et al. 1999; Lang, Kredan et al. 2000; Tasatargil, Dalaklioglu et al. 2004), 
indicating that oxidative stress plays a role in the impairment of 
endothelium-dependent relaxations by HC. In the present study, preincubation of rat 
aortic rings with HC severely impaired the concentration-dependent responses to ACh 
in terms of Emax, which was completely reversed by the intracellular O2' ROS 
scavenger tiron (1 mM). This finding is in accordance with Lang's observations that 
tiron could rescue the HC-impaired endothelium-dependent relaxations of rabbit 
aortic rings (Lang, Kredan et al. 2000), although in Lang's study, a higher 
concentration of tiron (10 mM) was used, possibly due to the difference in different 
vascular beds. 
Furthermore, HC treatment to cultured rat aortic endothelial cells increased the 
intracellular oxidative stress in a time-dependent manner, which had a trend to be 
reversed by tiron and was almost completely reversed to the control level by catalase. 
Both functional studies and DHE fluorescence experiments support the hypothesis 
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that HC impaired endothelium-dependent relaxations of rat aorta by producing 
intracellular oxidative stress. On the other hand, HC treatment did not alter the protein 
expression of SOD-1, SOD-2, eNOS, COX-1 and COX-2. This is reasonable when 
considering that the impairment of endothelium-dependent relaxations could be 
totally restored after the HC was washed away (data not shown). In this regard, it is 
likely that HC impairs the endothelium-dependent relaxations by affecting the activity 
rather than the expression of the proteins involved in the endothelium-dependent 
relaxation process. Indeed, there is evidence demonstrating that continued exposure 
to HC resulted in a 3-fold increase in endothelial cell SOD activity (Lang, Kredan et 
al. 2000). 
Preincubation of aorta with brassicasterol (30 |ig/mL and 10 ]Lig/mL), 
P-sitosterol (3 jiig/mL and 10 |Lig/mL), or stigmasterol (3 fig/mL and 10 jig/mL) for 30 
minutes before the addition of HC (300 |LIM) significantly reversed the attenuated 
endothelium-dependent relaxations. P-Sitosterol oxidation products (SOPs 30 |Lig/mL), 
on the other hand, did not improve the HC-induced impairment of 
endothelium-dependent relaxations to any degree. None of the phytosterols exhibited 
free radical-scavenging activity as determined by the DPPH assay. It is interesting 
that the brassicasterol alone could elevate the intracellular ROS levels as determined 
by DHE fluorescence, which is in contrast to the hypothesis that phytosterols protect 
the endothelium function by against oxidative stress produced by HC treatment. In 
line with this observation, evidences show that P-sitosterol stimulates the 
sphingomyelin cycle and increases ceramide production (Awad, von Holtz et al. 1998; 
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von Holtz, Fink et al. 1998) and ceramide has been shown to increase ROS in some 
cell types (Iwai, Kondo et al. 2003). Ceramide increases oxidative damage due to 
inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis 
(Iwai, Kondo et al. 2003). 
Brassicasterol increased intracellular ROS in endothelial cells, however, the 
increased ROS did not seem to play a role in the endothelial function of the aortas, as 
preincubation of the aortic rings with brassicasterol (30 |Lig/mL, 75 minutes) did not 
affect the concentration-dependent relaxations to ACh (Figure 4.12). In addition, 
preliminary data showed that HC (300 |iM) inhibited the NO production upon 10 |iM 
ACh in rat aortic endothelial cells (Figure 4.15). There is evidence showing that 
auto-oxidation of HC in plasma leads to oxidative inactivation of NO and impairs the 
endothelium function (Welch and Loscalzo 1998), which supports the observation in 
the present study. On the other hand, the effect of brassicasterol on reversing the 
HC-attenuated ACh-induced relaxation was completely abolished by pre-treatment 
with L-NAME, which suggests that the protective effect of brassicasterol was 
sensitive to the NO pathway. Indeed, brassicasterol has a trend to reverse the effect of 
HC by restoring the NO production in endothelial cells as reflected by DAF-FM 
fluorescence. This indicates that brassicasterol reverses the effect of HC by increasing 
the NO bioactivity, which was significantly inhibited by HC treatment. 
However, it is not known whether the increased ROS by brassicasterol plays a 
role in reversing the effect of HC. It is likely that brassicasterol exerts another effect 
on endothelium and/or VSMCs which encounters balance its effect on ROS and 
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thereby leads to a beneficial effect in HC-impaired arteries. 
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4.5 Conclusion and Future Work 
For the first time, the present work demonstrates the protective effect of 
phytosterols (e.g. brassicasterol, p-sitosterol and stigmasterol) against the HC-induced 
impairment of endothelium-dependent relaxations. Preincubation of rat aortic rings 
with HC significantly impaired the endothelium-dependent relaxations, which could 
be restored by phytosterols treatment. The hypothesis that HC impair the endothelial 
function by oxidative stress was confirmed by effect of the ROS scavenger tiron on 
restoring the endothelium-dependent relaxations in endothelium-intact aortic rings 
and on reversing the ROS elevated by HC treatment in primary cultured rat aortic 
endothelial cells. Furthermore, DAF-FM fluorescence showed that the NO production 
upon treatment with ACh was inhibited in rat aortic endothelial cells that were 
pretreated by HC. Phytosterols did not exert their effect by either direct free radical 
scavenge activity as determined by DPPH assay, or via altering the expression of the 
key proteins involved in modulating the intracellular ROS levels (e.g. SOD-1 and 
SOD-2), or decreasing the intracellular ROS levels generated by HC treatment. 
Instead, the brassicasterol treatment elevated the intracellular ROS, which could be 
reversed by H2O2 scavenger catalase. The investigation is not fulfilled due to the 
limited time. There is preliminary evidence indicating that brassicasterol reversed the 
effect of HC by enhancing the NO bioavailability in aortic endothelial cells. However, 
it is not known whether the brassicasterol-induced elevation of ROS levels plays a 
role in enhancing or impairing the bioavailability of NO. Some future experiments are 
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suggested: 1) The role of ROS would be investigated by testing whether the effect of 
phytosterols can be abolished by catalase treatment by functional study; 2) The effect 
of phytosterols on the catalase and SOD activity in primary cultured rat aortic 
endothelial cells would be determined; 3) Whether H2O2 can induce a 
concentration-dependent relaxation in both intact and endothelium-denuded rat aortic 
rings would be investigated to determine i f there are endothelium-dependent 
components of the vasorelaxant action of H2O2. 
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Chapter Five Conclusions and Future Work 
The three chapters from chapter two to chapter five introduce respectively the 
effect of SOPs on endothelium-dependent relaxations, on VSMC Ca^^ channels in 
endothelium-denuded aorta, and the effect of phytosterols on the HC-impaired 
endothelium-dependent relaxations of rat aorta. In chapter two, SOPs but not 
(3-sitosterol was found to attenuate endothelium-dependent relaxation. The 
SOPs-mediated attenuation of endothelium-dependent relaxation was reversed by 
inhibiting COX-1 or COX-2 and by scavenging ROS production. On the other hand, 
SOPs increased ROS production in the endothelial cells and also the expression of 
COX-2 protein in the endothelium, both of which was restored by ROS scavenger 
tempol. In summary, SOPs attenuated endothelium-dependent relaxation by 
increasing the production of ROS and COX-2 expression in the endothelium. The 
upregulated COX-2 expression was in turn caused by an increase in ROS production. 
On the other hand, SOPs played a different role in VSMC, where it relaxed the 
high K+-preconstricted endothelium-denuded aorta. The relaxant effect of SOPs was 
abolished by the VOCC opener Bay K 8644, potentiated by the NCX inhibitor nickel 
while not affected by thapsigargin (SERCA inhibitor) and ouabain (Na+/K+-ATPase 
inhibitor). Furthermore, SOPs inhibited concentration-dependent contractions to Phe, 
U46619 and K+. In summary, apart from its detrimental role in endothelium function, 
SOPs exerted potential VOCC blocking effect on VSMC. 
In chapter four, the present work demonstrates the protective effect of 
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phytosterols (e.g. brassicasterol, P-sitosterol and stigmasterol) against the HC-induced 
impairment of endothelium-dependent relaxations. Preincubation of rat aortic rings 
with HC significantly impaired the endothelium-dependent relaxations, which could 
be restored by phytosterols treatment. The hypothesis that HC impair the endothelial 
function by oxidative stress was confirmed by effect of the ROS scavenger tiron on 
restoring the endothelium-dependent relaxations in endothelium-intact aortic rings 
and on reversing the ROS elevated by HC treatment in primary cultured rat aortic 
endothelial cells. Furthermore, DAF-FM fluorescence showed that the NO production 
upon treatment with ACh was inhibited in rat aortic endothelial cells that were 
pretreated by HC. Phytosterols did not exert their effect by either direct free radical 
scavenge activity as determined by DPPH assay, or via altering the expression of the 
key proteins involved in modulating the intracellular ROS levels (e.g. SOD-1 and 
SOD-2), or decreasing the intracellular ROS levels generated by HC treatment. 
Instead, the brassicasterol treatment elevated the intracellular ROS, which could be 
reversed by H2O2 scavenger catalase. The investigation is not fulfilled due to the 
limited time. There is preliminary evidence indicating that brassicasterol reversed the 
effect of HC by enhancing the NO bioavailability in aortic endothelial cells. However, 
it is not known whether the brassicasterol-induced elevation of ROS levels plays a 
role in enhancing or impairing the bioavailability of NO. Some future experiments are 
suggested: 1) The role of ROS would be investigated by testing whether the effect of 
phytosterols can be abolished by catalase treatment by functional study; 2) The effect 
of phytosterols on the catalase and SOD activity in primary cultured rat aortic 
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endothelial cells would be determined; 3) Whether H2O2 can induce a 
concentration-dependent relaxation in both intact and endothelium-denuded rat aortic 
rings would be investigated to determine i f there are endothelium-dependent 
components of the vasorelaxant action of H2O2. 
The present study provides novel experimental evidence showing the beneficial 
effects of phytosterols on the endothelium function and paradoxical effect of SOPs on 
the vasculature, that is, harmful effects of SOPs on the endothelium function while 
potential VOCC blocking effect on VSMC. In summary, the safety profile of dietary 
consumption of phytosterols in the vascular system needs further examination. 
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